WO2008046328A1 - A levorotatory lactonohydrolase producing strain and its use for producing chiral oxyacid - Google Patents

A levorotatory lactonohydrolase producing strain and its use for producing chiral oxyacid Download PDF

Info

Publication number
WO2008046328A1
WO2008046328A1 PCT/CN2007/070598 CN2007070598W WO2008046328A1 WO 2008046328 A1 WO2008046328 A1 WO 2008046328A1 CN 2007070598 W CN2007070598 W CN 2007070598W WO 2008046328 A1 WO2008046328 A1 WO 2008046328A1
Authority
WO
WIPO (PCT)
Prior art keywords
lactone
hydroxy
butyrolactone
fusarium
substrate
Prior art date
Application number
PCT/CN2007/070598
Other languages
French (fr)
Chinese (zh)
Other versions
WO2008046328A8 (en
Inventor
Jianhe Xu
Xian Zhang
Jiang Pan
Yi Xu
Bing Chen
Original Assignee
East China University Of Science And Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by East China University Of Science And Technology filed Critical East China University Of Science And Technology
Priority to CN2007800383401A priority Critical patent/CN101535467B/en
Publication of WO2008046328A1 publication Critical patent/WO2008046328A1/en
Publication of WO2008046328A8 publication Critical patent/WO2008046328A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42Hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/77Fusarium

Definitions

  • the present invention relates to a highly selective L-lactone hydrolase producing strain and a technical method for preparing a chiral hydroxy acid or a corresponding lactone using the strain.
  • Hydroxy acids such as lactic acid, malic acid, tartaric acid, citric acid, and gluconic acid, are a very important class of organic acids that have unique physiological functions in living organisms and are very useful in the food/feed industry. Functional additive. This situation is very similar to amino acids, and the two can also be transformed into each other under certain conditions. Some non-natural hydroxy acids, especially optically active chiral hydroxy acids, can also be used as "structural blocks" for the chemical synthesis of various natural products and drug molecules.
  • the ⁇ -hydroxy acid, ⁇ -hydroxy acid and hydroxyl group at the terminal ⁇ -hydroxy acid can be dehydrated and closed under acidic conditions to form a four-membered ring, a five-membered ring or a polycyclic lactone.
  • the compounds are referred to as ⁇ -lactone, ⁇ -lactone or ⁇ -lactone, respectively.
  • ⁇ -lactones and ⁇ -lactones generally have a fruity aroma, while certain macrocyclic ⁇ -lactones have a musky scent, which has important applications in the food and cosmetic industries.
  • certain insect hormones and plant growth regulators are also lactone compounds.
  • the lactone can be hydrolyzed to the corresponding hydroxy acid, and can be easily condensed with other nucleophiles such as an alcohol/amine to form a plurality of derivatives such as a hydroxy ester/hydroxy amide, and thus has a wide range of uses in the fine chemical and pharmaceutical industries.
  • ⁇ -lactone is relatively common and useful because of its stable five-membered ring structure.
  • a ⁇ -lactone which is mono- or poly-substituted at the ⁇ / ⁇ -position, the structure of which is present in many natural products, and compounds containing such a structure tend to have various biological activities (for example, cytotoxicity and antifungal activity; Such compounds may be screened as new anti-tumor or anti-bacterial drugs.
  • Such compounds generally contain asymmetric chiral carbon atoms, and their biological activities are often associated with their optical activity.
  • the synthesis of optically active lactone compounds and the study of their biological activity and structure-activity relationship is an important task that helps people discover new drugs.
  • ⁇ -hydroxy- ⁇ -butyrolactone is a useful optically active substance.
  • Copy of Fuji Pharmaceutical Industry Hui Si et al. JP9308497) used a selective ring-opening hydrolysis of ⁇ -hydroxy- ⁇ -butyrolactone catalyzed by Fusarium oxysporum to obtain (S)-(+)-a-hydroxyazinolactone and (R) -(+)-a-hydroxy- ⁇ -butyric acid, which is acidified and lactonized to give an optical purity of 96% (RH;-;)-a-hydroxy- ⁇ -butyrolactone in a yield of 40 %.
  • ⁇ -hydroxy- ⁇ -butyrolactone is a very important chiral structural block
  • (- ⁇ -hydroxy- ⁇ -butyrolactone is a hypolipidemic drug atorvastatin, neurotransmitter L-(-)-meat Alkali, HIV protease inhibitor amprenavir, a key intermediate for the treatment of dermatological drugs hydroxyeicosatetraenoic acid, anticancer drug Aplysistatint, etc.
  • (SH-)-P-hydroxy- ⁇ -butyl Lactone reduction can give 05 (-)- ⁇ -hydroxytetrahydrofuran, which is an important intermediate for AIDS treatment; convert (-)- ⁇ -hydroxy- ⁇ -butyrolactone to (-)-5- Hydroxymethyl-1,3-oxazolin-2-one can be used to obtain the latest generation of antibacterial drugs.
  • many important natural compounds can be synthesized from (-)- ⁇ -hydroxy- ⁇ -butyrolactone, and RM+)-P-hydroxy- ⁇ -butyrolactone is also a very important organic synthesis intermediate.
  • (-)- ⁇ -hydroxy- ⁇ -butyrolactone is synthesized by chemical method.
  • D-(-)-pantolactone is a preparation of D-pantothenate and D-panthenol.
  • D-calcium pantothenate also known as vitamin ⁇ 5
  • Etzyme MicfobTechnol, 1988, 10: 689-690 Separation of 0-acetyl pantolactone using lipase, Adam et al (Synthesis, 1988, 5: 373 ⁇ 375) was prepared using a nitrilase (- - Pantolactone, also known (Appl.
  • the technical problem to be solved by the present invention is to disclose a L-lactone hydrolase-producing bacterium and a method thereof for preparing a chiral hydroxy acid to overcome the drawbacks of the prior art.
  • a strain of Fusarium proliferatum Nirenberg ECU2002 producing L-lactone hydrolase is provided, and the accession number is CGMCC 1494.
  • the bacterium comprises a DNA having the nucleotide sequence shown at positions 86 to 1206 of SEQ ID NO: 1. This DNA encodes a L-lactone hydrolase.
  • the DNA has the nucleotide sequence shown in SEQ ID NO: 1 or SEQ ID NO: 2.
  • step (2) (2) contacting the culture of step (1) or its extract with a racemic chiral lactone substrate (gP ( ⁇ lactone substrate;) to hydrolyze (-)-lactone to form (+) - Hydroxy acid.
  • a racemic chiral lactone substrate gP ( ⁇ lactone substrate;)
  • the Fusarium proliferatum Nirenberg ECU2002 is fermented in a medium containing carbon, nitrogen, phosphorus and an inorganic salt to obtain a culture;
  • the culture obtained in the step (1) or the extract thereof is used as a catalyst to catalyze the enantioselective hydrolysis of the lactone substrate, and the unhydrolyzed (+)-lactone is separated and removed, and obtained by (-)-hydroxy acid formed by hydrolysis of lactone;
  • Said lactone substrate includes (but is not limited to): ⁇ -butyrolactone, ⁇ -hydroxy- ⁇ -butyrolactone, ⁇ -hydroxy- ⁇ , ⁇ - Dimethyl- ⁇ -butyrolactone, ⁇ -acetyl- ⁇ -butyrolactone, ⁇ -hydroxy- ⁇ -butyrolactone, n-butylphthalide, and the like.
  • the extract of the culture is selected from the group consisting of:
  • Immobilized cells or immobilized cell extracts are Immobilized cells or immobilized cell extracts.
  • composition and concentration of the medium are as follows: glycerol 10 to 50 g/L, peptone 1 to 20 g/L, yeast extract 1 to 20 g/L, ammonium nitrate 1 to 10 g/ L, inorganic salt: NaCl 0.1 ⁇ 2 g/L; MgSO 4 '7H 2 O 0.1 ⁇ 2 g/L; FeSO 4 '7H 2 O 0.01 ⁇ 0.05 g/L; ZnSO 4 '7H 2 O 0.01 ⁇ 0.05 g/ L; CuSO 4 '5H 2 O 0.001 ⁇ 0.01 g/L;
  • the fermentation conditions are:
  • the inoculum based on the volume of the fermentation medium is 1 to 10% by volume, and the fermentation time is 12-48 ho.
  • the concentration of the lactone substrate is from 1 to 75% by weight, and the amount of the catalyst based on the weight of the substrate lactone is from 0.25 to 1.5 grams of cells per gram of lactone or 0.25 to 10 units of enzyme per Ketone, reaction temperature is 25 ⁇ 40 °C, pH 6.0 ⁇ 8.0, reaction time is 0.1-40 ho
  • the lactone substrate is ( ⁇ )- ⁇ -hydroxy- ⁇ -butyrolactone.
  • the lactone substrate is ( ⁇ )-pantolactone.
  • the catalyst is in any of the following forms:
  • the method further comprises the step of: dehydrating the (+)-hydroxy acid under acidic conditions to obtain a (-)-lactone.
  • the acidic condition is pH 1-4.
  • the use of the Fusarium bacterium characterized in that it is used to produce a L-lactone hydrolase catalyst for the preparation of a chiral hydroxy acid or a chiral lactone.
  • the L-lactone-producing bacterium of the present invention Fusarium oxysporum (also known as Fusarium) F ⁇ ar/w proliferatum Nirenberg ECU2002, is a uniquely isolated (-)-separated from the soil recently. Ester hydrolase-producing bacteria, which was deposited at the China General Microorganisms Collection (CGMCC) on October 17, 2005, with the accession number CGMCC 1494.
  • This strain was identified as a Fusarium proliferatum Nirenberg group by the German DSMZ company.
  • the F ⁇ ar/w proliferatum ECU2002 of the present invention is a pink fungus, and has many small conidia in the initial stage, and the enzyme fermentation time is as short as 1 to 2 days, while the Fusarium moniliforme SW-902 and Fusarium oxysporum reported in the literature.
  • AKU3702 is a white fungus with spores larger in beads.
  • the fermentation time of Fusarium moniliforme SW-902 is 2 ⁇ 3 days.
  • the fermentation time of F ari oxysporum AKU3702 is 5 ⁇ 7 days longer, while Fusarium oxysporum AKU3702 is more. It is a phytopathogenic bacterium.
  • the Fusarium proliferatum ECU 2002 of the present invention can hydrolyze various lactone substrates to form corresponding chiral hydroxy acids, and is highly resistant to the concentration of the substrate, such as catalyzing the hydrolysis of D-(-)-pantolactone.
  • the substrate concentration can be as high as 75% w/v (the substrate concentration reported in the literature is generally 10 to 30%, w/v). After recrystallization, the optical purity of the product (-)-lactone exceeds 99%. .
  • the Fusarium oxysporum (F ⁇ ar/w proliferatum Nirenberg ECU2002) of the present invention can be used to prepare a chiral hydroxy acid, and includes the following steps:
  • composition and concentration (g/L) of the medium are as follows:
  • C the inoculum amount based on the medium volume is 1 to 10% ⁇ / ⁇ , the culture time is 12 to 48 hours;
  • the concentration of the substrate lactone is 1 to 75% (w/v), and the catalyst is used in an amount of 0.25 to 1.5 g of cells per gram of lactone or 0.25 to 10 units of enzyme per gram of lactone based on the weight of the substrate lactone.
  • concentration of the substrate lactone is 1 to 75% (w/v)
  • the catalyst is used in an amount of 0.25 to 1.5 g of cells per gram of lactone or 0.25 to 10 units of enzyme per gram of lactone based on the weight of the substrate lactone.
  • reaction time is 0. 1-40 h;
  • the enzyme unit (U) is defined as the amount of enzyme required to catalyze the hydrolysis of 1 ⁇ ⁇ -butyrolactone to the corresponding hydroxy acid in 1 min under the above conditions.
  • Said catalyst is any of the following forms:
  • the lactone substrate includes, but is not limited to: ⁇ -butyrolactone, ⁇ -hydroxy- ⁇ -butyrolactone, ⁇ -hydroxy- ⁇ , ⁇ -dimethyl- ⁇ -butyrolactone (commonly known as a general solution) Acid lactone;), ⁇ -acetyl- ⁇ -butyrolactone, ⁇ -hydroxy- ⁇ -butyrolactone, n-butylphthalide, and the like.
  • a preferred substrate lactone is ( ⁇ )- ⁇ -hydroxy- ⁇ -butyrolactone.
  • a preferred substrate lactone is ( ⁇ )-pantolactone.
  • the strain of the invention has stable enzyme production and good stereoselectivity, and can directly use the mycelium obtained by fermentation as an enzyme source to hydrolyze the racemic lactone to obtain a chiral hydroxy acid with high optical purity and the remaining lactone.
  • Figure 1 shows the results of multi-batch hydrolysis resolution of 10% (; wA a-hydroxy- ⁇ -butyrolactone) catalyzed by immobilized cells.
  • Figure 2 shows the results of multi-batch hydrolysis resolution of 20% (; w/v) pantolactone catalyzed by immobilized cells.
  • Figure 3 shows the results of multi-batch hydrolysis resolution of 35% (; w/v) pantolactone catalyzed by immobilized enzyme.
  • Figure 4 shows the progress of the catalytic resolution of 75% (; w/v) pantolactone by immobilized enzyme.
  • Bevel and plate medium g/L: glycerol 30, yeast extract 7.5, peptone 7.5, agar 20. Sterilize at 121 °C for 15 minutes, sterilize, cool, plate, inoculate, and incubate at 30 °C for 2 days.
  • Fermentation medium g/L: glycerol 30; peptone 10; yeast extract 10; NH 4 NO 3 3; inorganic salt (g/L) (NaCl 1; MgSO 4 '7H 2 O 1; FeSO 4 '7H 2 O 0.02; ZnSO 4 7H 2 O 0.03; CuSO 4 '5H 2 O 0.005); pH 7.5.
  • a series of lactones are substrates, the substrate concentration is ⁇ , the reaction volume is 10 mL, and 0.2 g of immobilized cells (cells obtained by cross-linking with 15 mM glutaraldehyde at 30 ° C for 3 h) are placed at 30 . C. The activity was measured after 0.1 ⁇ 0.5 h of reaction under magnetic stirring.
  • Table 2 lists the relative viability of immobilized cells when different lactones are hydrolyzed. With the activity of ⁇ -butyrolactone being 100%, the hydrolysis effect of immobilized cells on the more complex lactone (such as n-butylphthalide) is not obvious, and the activity of the enzyme is only 25%.
  • the immobilized cells showed high activity against ⁇ -substituted lactone.
  • the substrate was ⁇ -hydroxy- ⁇ -butyrolactone
  • the activity was the highest, which was 54 times that of ⁇ -butyrolactone.
  • the viable cell viability was 21 times that of ⁇ -butyrolactone 14.7.
  • Table 2 Catalytic Activity of Immobilized Cells on a Series of Lactone Compounds Example No. Substrate Structural Formula Relative Activity (%) Example 3 ⁇ -butyrolactone 100 ⁇ 1
  • Example 5 ( ⁇ )- ⁇ -hydroxy- ⁇ -butyl awake 5541 ⁇ 84
  • Example 6 (earth) - ⁇ -hydroxy- ⁇ -butyl awake 374
  • Example 7 (+)- ⁇ -hydroxy- ⁇ -butyl Wake up 129 ⁇ 3
  • Example 8 (-) - ⁇ -hydroxy- ⁇ -butyl awake 517 ⁇ 16
  • Example 9 (earth) - pantolactone 1468 ⁇ 23
  • Example 12 ( ⁇ )- ⁇ -acetyl- ⁇ -butyl awake
  • Example 13 n-butylphenyl hydrazine
  • Example 14 ⁇ : 17 The crude enzyme extract of Fusarium proliferatum ECU2002 was used to separate the chirality with ECU2002 crude enzyme extract as the enzyme source, ( ⁇ )- ⁇ -butyrolactone, ( ⁇ )- ⁇ -hydroxy- ⁇ -butyl Lactone, (+)- ⁇ -hydroxy- ⁇ -butyrolactone and ( ⁇ )-pantolactone as substrate, reaction volume 20 mL, substrate concentration 100 mM, input crude enzyme 13 U, reaction temperature
  • the reaction time was 0.2 to 12 h at 30 ° C, and the pH of the reaction solution was kept constant at 7.0 by dropwise addition of NaOH, and the conversion was calculated from the alkali consumption.
  • the (-; )-lactone substrate was selectively hydrolyzed to form (+)-hydroxy acid, and the conversion rate was as high as 38.2%, and (10) -
  • the optical purity of the product (-)-pantolactone is up to 98.2% ee.
  • the optical purity of the product (-)- ⁇ -hydroxy- ⁇ -butyrolactone was maintained between 93-96% ee.
  • the above results indicate that the immobilized cells have good enantioselectivity and excellent operational stability when subjected to hydrolysis-resolving reaction of ⁇ -hydroxy- ⁇ -butyrolactone.
  • Example 19 Immobilized cells catalyze the multi-batch hydrolysis of pantolactone (concentration 20% w/v) at a substrate ( ⁇ )-pantolactone concentration of 1.5 M (20% w/v)
  • pantolactone concentration 20% w/v
  • substrate ⁇ -pantolactone concentration of 1.5 M (20% w/v)
  • 15 g of cells immobilized by glutaraldehyde cross-linking were added, and reacted at 30 ° C, 160 rpm for 10 h, and ammonia was added to adjust the pH of the reaction to 6.5 to 7.0.
  • the operation was repeated 30 times with free cells as a control. As a result, as shown in FIG.
  • the immobilized catalyst can be reused for more than 30 times, and the enzymatic hydrolysis reaction can be carried out multiple times, and both of them have satisfactory resolution effects, and have potential industrial application value.
  • Example 20 Immobilized enzyme catalyzed multi-batch hydrolysis of pantolactone (concentration: 35% w/v)
  • Example 21 Catalytic resolution of high concentration (75% w/v) of (earth)-pantolactone by immobilized enzyme in a 20 mL reaction system with a substrate concentration of 5.7 M (; 75% W / V ) (; ⁇ )-pantolactone, and put 40.0 U of immobilized enzyme, react at 160 rpm, 30 °C, add ammonia (3 M) to control the reaction pH at 7.2.
  • the progress of the reaction is shown in Fig. 4. After 36 h of reaction, the conversion rate is 36.8%.
  • the optical purity of the product (-)-pantolactone is still >90% ee.
  • the optical purity of the product after recrystallization can be Reach > 99% ee.
  • Example 22 Cloning of the lactone hydrolase gene
  • the mRNA isolated from 2 was used as a template to synthesize the first strand of cDNA, and the instructions were carried out according to the instructions of the Biosynthetics cDNA Synthesis Kit.
  • ⁇ I substance 1 (SEQ ID NO: 3): GGAACATATGCCTTCTTCCATTTCTGT (lined part of Nde I restriction site)
  • Primer 2 (SEQ ID NO: 4): GGACCATATGGCTAAGCTTCCTTCTACG
  • ⁇ I I 3 (SEQ ID NO: 5): AAGGGGATCCCTAATCATAGAGCTTGGGAC (the part of the line is the BamHI restriction site)
  • the primers 1, 3 and primers 2 and 3 were used to amplify the L-lactone hydrolase cDNA gene with the first strand of the total cDNA as a template.
  • the PCR parameters were 94 °C for 30 s, 57 °C for 30 s, and 72 °C for 80 s. After repeating 30 cycles, continue to extend 10 min at 72 °C.
  • the PCR product was identified by electrophoresis on a 0.0% agarose gel.
  • the PCR product was approximately 25 ⁇ l, and the fragment of interest was recovered by electrophoresis on 0.7% agarose.
  • the DNA gel recovery kit is used for recovery. The method is described in the DNA gel recovery kit.
  • the recovered target fragment is ligated to the vector pMD 18-T (TaKaRa), and the specific method is as follows.
  • the PMD 18-T vector kit instructions were used to construct recombinant plasmids pMD 18-T-12 (primer 1 and primer 3) and pMD 18-T-14 (primer 2 and primer 3). The recombinant plasmid was then electroporated into the E. co//JM109 host strain as described in the literature.
  • the transformed bacterial solution was inoculated into 3 ml of LB medium containing 50 ⁇ 8 / ⁇ 1 ampicillin (Amp), and cultured at 37 ° C overnight.
  • the plasmid was extracted by alkaline lysis, and the PCR product was identified by restriction endonuclease Nde I and BamHI.
  • the PCR product was identified by 0.1% agarose gel electrophoresis, and the positive clones were screened and verified by sequencing.
  • PCR was carried out using primer 1 and primer 3, and the obtained PCR product sequence is shown in SEQ ID NO: 1.
  • PCR was carried out using primer 2 and primer 3, and the obtained PCR product sequence is shown in SEQ ID NO: 2.
  • the Fusarium proliferat m Nirenberg ECU 2002 of the present invention was deposited on October 17, 2005 at the General Microbiology Center of the China Microbial Culture Collection Management Committee (Beijing, China) under the number CGMCC 1494.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A specific levorotatory lactonohydrolase producing strain and its use for producing chiral oxyacid are disclosed. The enzyme producing stain is Fusarium proliferatum Nirenberg ECU2002 with deposit number CGMCC 1494. The chiral oxyacid preparing method includes: (1) using the fungus mycelium, rough enzyme extract or their immobilization derivative as biocatalyst; (2) processing antipode selectivity hydrolysis resolution for a series of racemic chirality lactones to gain many optically active (+)-oxyacids and (+)-lactones which can be hydrolyzed into (-)-oxyacids; (+)-alpha-hydroxyl-beta, beta-dimethyl-gamma-butyric acid which is D- (+)-pantoic acid; and simple acidizing to gain chirality intermediate D-(-)-pantoic acid lactone widely used in preparing feed and daily chemical engineering industry.

Description

左旋内酯水解酶产生菌及其用于制备手性羟基酸的方法 技术领域  L-lactone hydrolase producing bacteria and method for preparing chiral hydroxy acid thereof
本发明涉及一株高选择性左旋内酯水解酶产生菌以及利用该菌株制备手 性羟基酸或相应内酯的技术方法。 技术背景  The present invention relates to a highly selective L-lactone hydrolase producing strain and a technical method for preparing a chiral hydroxy acid or a corresponding lactone using the strain. technical background
羟基酸, 例如乳酸、 苹果酸、 酒石酸、 柠檬酸和葡萄糖酸等, 是一类非常 重要的有机酸, 在生物体内具有独特的生理功能, 而在食品 /饲料工业上又是一 类非常有用的功能添加剂。 这种情形与氨基酸十分相似, 二者在一定条件下也 可以相互转化。 一些非天然的羟基酸, 特别是具有光学活性的手性羟基酸, 还 可以作为 "结构砌块"用于各种天然产物和药物分子的化学合成。  Hydroxy acids, such as lactic acid, malic acid, tartaric acid, citric acid, and gluconic acid, are a very important class of organic acids that have unique physiological functions in living organisms and are very useful in the food/feed industry. Functional additive. This situation is very similar to amino acids, and the two can also be transformed into each other under certain conditions. Some non-natural hydroxy acids, especially optically active chiral hydroxy acids, can also be used as "structural blocks" for the chemical synthesis of various natural products and drug molecules.
除单纯的 α-羟基酸之外, β-羟基酸、 γ-羟基酸和羟基在末端的 ω-羟基酸均 可以在酸性条件下脱水闭环形成四元环、 五元环或多元环的内酯化合物, 分别 称为 β-内酯、 γ-内酯或 ω-内酯。 β-内酯和 γ-内酯通常具有水果香味, 而某些大 环 ω-内酯具有麝香香味, 它们在食品和化妆品工业中有重要应用价值。 另外, 某些昆虫激素和植物生长调节剂也是内酯化合物。 内酯不但可以水解为相应的 羟基酸, 而且可以容易地与其它的醇 /胺等亲核试剂缩合形成多种羟基酯 /羟基 酰胺等衍生物, 因此在精细化工和制药工业具有广泛用途。  In addition to pure α-hydroxy acid, the β-hydroxy acid, γ-hydroxy acid and hydroxyl group at the terminal ω-hydroxy acid can be dehydrated and closed under acidic conditions to form a four-membered ring, a five-membered ring or a polycyclic lactone. The compounds are referred to as β-lactone, γ-lactone or ω-lactone, respectively. Β-lactones and γ-lactones generally have a fruity aroma, while certain macrocyclic ω-lactones have a musky scent, which has important applications in the food and cosmetic industries. In addition, certain insect hormones and plant growth regulators are also lactone compounds. The lactone can be hydrolyzed to the corresponding hydroxy acid, and can be easily condensed with other nucleophiles such as an alcohol/amine to form a plurality of derivatives such as a hydroxy ester/hydroxy amide, and thus has a wide range of uses in the fine chemical and pharmaceutical industries.
在各种内酯化合物中, γ-内酯由于具有稳定的五元环结构, 因此比较常见 和有用。在 α/β-位被单取代或多取代的 γ-内酯,其结构存在于许多天然产物中, 包含这种结构的化合物往往具有多种生物活性 (例如细胞毒性和抗真菌活性;), 因此该类化合物有可能被筛选为新的抗肿瘤或抗菌药物。 这类化合物分子中一 般含有不对称的手性碳原子, 它们的生物活性往往是与它们的光学活性联系在 一起的。 合成光学活性的内酯化合物, 并对其生物活性和构效关系进行研究是 一项具有重要意义的工作, 有助于人们发现新型药物。  Among various lactone compounds, γ-lactone is relatively common and useful because of its stable five-membered ring structure. a γ-lactone which is mono- or poly-substituted at the α/β-position, the structure of which is present in many natural products, and compounds containing such a structure tend to have various biological activities (for example, cytotoxicity and antifungal activity; Such compounds may be screened as new anti-tumor or anti-bacterial drugs. Such compounds generally contain asymmetric chiral carbon atoms, and their biological activities are often associated with their optical activity. The synthesis of optically active lactone compounds and the study of their biological activity and structure-activity relationship is an important task that helps people discover new drugs.
通过传统的化学方法合成光学纯手性内酯需要经过复杂的步骤并使用特 殊的催化剂, 通常产率不高, 存在污染和毒性问题等种种缺点, 而生物催化合 成法具有绿色化学的优点, 方法简单、 条件温和、 反应较快, 日益获得广泛的 关注。  The synthesis of optically pure chiral lactones by conventional chemical methods requires complex steps and the use of special catalysts, usually with low yields, contamination and toxicity problems, and biocatalytic synthesis has the advantages of green chemistry. Simple, mild, and responsive, and increasingly gaining widespread attention.
例如, α-羟基 -γ-丁内酯是一种有用的光学活性物质。 富士药品工业的坂本 惠司等 (JP9308497)使用一种镰孢霉菌 Fusarium oxysporum催化 α-羟基 -γ-丁内 酯的选择性开环水解, 得到 (S)-(+)-a-羟基卞丁内酯和 (R)-(+)-a-羟基 -γ-丁酸, 后 者经过酸化内酯化,得到光学纯度 96%的 (; RH;-;)-a-羟基 -γ-丁内酯,收率达 40%。 For example, α-hydroxy-γ-butyrolactone is a useful optically active substance. Copy of Fuji Pharmaceutical Industry Hui Si et al. (JP9308497) used a selective ring-opening hydrolysis of α-hydroxy-γ-butyrolactone catalyzed by Fusarium oxysporum to obtain (S)-(+)-a-hydroxyazinolactone and (R) -(+)-a-hydroxy-γ-butyric acid, which is acidified and lactonized to give an optical purity of 96% (RH;-;)-a-hydroxy-γ-butyrolactone in a yield of 40 %.
又如, β-羟基 -γ-丁内酯是非常重要的手性结构砌块, ( -β-羟基 -γ-丁内酯 是降血脂药物阿伐他汀, 神经介质 L-(-)-肉碱, HIV 蛋白酶抑制剂氨普那韦 (Amprenavir) , 治疗皮肤病药羟基二十碳四烯酸, 抗癌药 Aplysistatint等药物的 关键中间体。 将 (SH-)-P-羟基 -γ-丁内酯还原可得 05 (-)-β-羟基四氢呋喃, 后者 是艾滋病治疗药物的一种重要中间体; 将 (-)-β-羟基 -γ-丁内酯转化为 (-)-5-羟甲 基 - 1,3-唑啉 -2-酮可得最新一代的抗菌药物。 此外, 从 (-) -β-羟基 -γ-丁内酯出发 还可以合成很多重要的天然化合物, 而 (RM+)-P-羟基 -γ-丁内酯也是一种非常重 要的有机合成中间体。 目前主要由化学法合成得到 (-)-β-羟基 _γ-丁内酯。 Henrot (Synth Commun, 1986, 16(2): 183〜 190)以 (-) -苹果酸为原料, 经甲酯化生成 (-) - 苹果酸二甲酯, 再经还原和酯交换后生成(-) -β-羟基 -γ-丁内酯。 Tanaka (Synthesis, 1987, 6: 570〜573)以 D-异抗坏血酸为原料,经六步反应合成了 (-)-β- 羟基 -γ-丁内酯。 Suzuki 等(E ym. Microb. Technol., 1999, 24: 13-20)使用 Pseudomonas sp.以及 Enterobacter sp.等微生物的脱氯酶选择性地对外消旋 4-氯 In another example, β-hydroxy-γ-butyrolactone is a very important chiral structural block, (-β-hydroxy-γ-butyrolactone is a hypolipidemic drug atorvastatin, neurotransmitter L-(-)-meat Alkali, HIV protease inhibitor amprenavir, a key intermediate for the treatment of dermatological drugs hydroxyeicosatetraenoic acid, anticancer drug Aplysistatint, etc. (SH-)-P-hydroxy-γ-butyl Lactone reduction can give 05 (-)-β-hydroxytetrahydrofuran, which is an important intermediate for AIDS treatment; convert (-)-β-hydroxy-γ-butyrolactone to (-)-5- Hydroxymethyl-1,3-oxazolin-2-one can be used to obtain the latest generation of antibacterial drugs. In addition, many important natural compounds can be synthesized from (-)-β-hydroxy-γ-butyrolactone, and RM+)-P-hydroxy-γ-butyrolactone is also a very important organic synthesis intermediate. Currently (-)-β-hydroxy-γ-butyrolactone is synthesized by chemical method. Henrot (Synth Commun, 1986 , 16(2): 183~ 190) Using (-)-malic acid as raw material, methyl esterification to form (-)-dimethyl malate, followed by reduction and transesterification to form (-)-β-hydroxyl -γ-丁Tanaka (Synthesis, 1987, 6: 570~573) synthesized (-)-β-hydroxy-γ-butyrolactone by a six-step reaction using D-isoascorbic acid as a raw material. Suzuki et al. (E ym. Microb. Technol., 1999, 24: 13-20) Selectively racemic 4-chloro-chloride using dechlorinating enzymes such as Pseudomonas sp. and Enterobacter sp.
-3-羟基丁酸酯的 (-) -对映体进行脱氯反应, 得到 (-) -β-羟基 -γ-丁内酯和剩余的 (+)_4_氯 _3_羟基丁酸酯。 Dechlorination of the (-)-enantiomer of -3-hydroxybutyrate to give (-)-β-hydroxy-γ-butyrolactone and the remaining (+)_ 4 _chloro- 3 -hydroxybutyric acid ester.
再如, (-) -α-羟基 -β, β-二甲基 -γ-丁内酯, 俗称 D- (-) -泛解酸内酯, 是制备 D-泛酸钙和 D-泛醇的重要合成中间体。 D-泛酸钙 (又称维生素 Β5)是重要的维生 素之一, 广泛用于医药、饲料和食品行业中。
Figure imgf000004_0001
等 Enzyme MicfobTechnol, 1988, 10: 689〜690)使用脂肪酶对 0-乙酰泛解酸内酯进行拆分, Adam 等 (Synthesis, 1988, 5: 373〜375)则使用腈水解酶制备了 (-) -泛解酸内酯, 也有人 (Appl. Microbiol, 1974, 27( 1): 130—134; Enzyme Microb Technol, 1987, 9(7): 41 1〜416; Agric Biol Chem, 1987, 51 : 289—290; Agric Biol Chem, 1987, 51 : 301 1〜3016; Tetrahedron: Asymmetry, 1994, 5(8): 1419〜 1423)尝试利用氧化还 原酶通过不对称氧化还原反应制备 (-)-泛解酸内酯; 1994 年日本京都大学 Shimizu 等 (AppL Microbiol. Biotechnol, 1995, 44: 333〜338)使用 Fusarium oxysporum AKU3702催化拆分消旋泛解酸内酯; 2002年我国江南大学孙志浩等 MProcess Biochem, 2002, 38: 545〜 549)使用 Fusarium moniliforme SW-902酶 法拆分泛解酸内酯, 均得到光学纯度较高的 D- (-) -泛解酸内酯。 尽管在现有的手性羟基酸合成技术中, 无论是化学拆分法还是现有的生物 法都已取得一定进展, 但仍然存在底物浓度比较低, 产物光学纯度不够高, 催 化剂活力不够强等或这或那的缺点, 影响了这些方法在工业上的应用效果。 并 且, 目前找到的适合生物法产生手性羟基酸的菌株大多只能针对单一或少数的 底物, 应用不广泛。 发明内容
For example, (-)-α-hydroxy-β, β-dimethyl-γ-butyrolactone, commonly known as D-(-)-pantolactone, is a preparation of D-pantothenate and D-panthenol. Important synthetic intermediates. D-calcium pantothenate (also known as vitamin Β 5 ) is one of the important vitamins and is widely used in the pharmaceutical, feed and food industries.
Figure imgf000004_0001
Etzyme MicfobTechnol, 1988, 10: 689-690) Separation of 0-acetyl pantolactone using lipase, Adam et al (Synthesis, 1988, 5: 373~375) was prepared using a nitrilase (- - Pantolactone, also known (Appl. Microbiol, 1974, 27(1): 130-134; Enzyme Microb Technol, 1987, 9(7): 41 1~416; Agric Biol Chem, 1987, 51: 289-290; Agric Biol Chem, 1987, 51 : 301 1~3016; Tetrahedron: Asymmetry, 1994, 5(8): 1419~ 1423) Trying to prepare (-)-general solution by asymmetric redox reaction using oxidoreductase Acid lactone; In 1994, Shimizu et al. (AppL Microbiol. Biotechnol, 1995, 44: 333~338) of Kyoto University used Fusarium oxysporum AKU3702 to catalyze the resolution of racemic pantolactone; in 2002, Moshi Biochem of Jiangnan University, China, etc. 2002, 38: 545~ 549) The pantolactone was resolved by Fusarium moniliforme SW-902 enzymatic method, and D-(-)-pantolactone was obtained with higher optical purity. Although in the existing chiral hydroxy acid synthesis technology, both the chemical resolution method and the existing biological method have made some progress, there are still relatively low substrate concentrations, the product optical purity is not high enough, and the catalyst activity is not strong enough. The shortcomings of this or the other affect the industrial application of these methods. Moreover, most of the strains currently found to be suitable for the production of chiral hydroxy acids by biological methods can only be used for single or a small number of substrates, and are not widely used. Summary of the invention
本发明人经过长期的研究和反复的筛选试验, 意外地筛选到一株可产生左 旋内酯水解酶的镰孢菌, 该菌株对底物的耐受性很强, 可催化多种底物内酯的 对映选择性水解, 生成相应的手性羟基酸, 并且其催化能力强, 产物光学纯度 高。 因此, 本发明解决的技术问题是公开一株左旋内酯水解酶产生菌及其用于 制备手性羟基酸的方法, 以克服现有技术的缺陷。  After long-term research and repeated screening tests, the inventors accidentally screened a strain of Fusarium that produces L-lactone hydrolase, which is highly resistant to substrates and can catalyze a variety of substrates. The enantioselective hydrolysis of the ester produces the corresponding chiral hydroxy acid with high catalytic activity and high optical purity of the product. Therefore, the technical problem to be solved by the present invention is to disclose a L-lactone hydrolase-producing bacterium and a method thereof for preparing a chiral hydroxy acid to overcome the drawbacks of the prior art.
在本发明的第一方面, 提供一株产左旋内酯水解酶的镰孢菌 Fusarium proliferatum Nirenberg ECU2002, 保藏号为 CGMCC 1494。  In a first aspect of the present invention, a strain of Fusarium proliferatum Nirenberg ECU2002 producing L-lactone hydrolase is provided, and the accession number is CGMCC 1494.
在另一优选例中, 所述的菌含有一 DNA, 所述的 DNA具有 SEQ ID NO: 1 中第 86- 1206位所示的核苷酸序列。 该 DNA编码一种左旋内酯水解酶。  In another preferred embodiment, the bacterium comprises a DNA having the nucleotide sequence shown at positions 86 to 1206 of SEQ ID NO: 1. This DNA encodes a L-lactone hydrolase.
在另一优选例中, 所述的 DNA具有 SEQ ID NO: 1或 SEQ ID NO: 2所示 的核苷酸序列。  In another preferred embodiment, the DNA has the nucleotide sequence shown in SEQ ID NO: 1 or SEQ ID NO: 2.
在本发明的第二方面, 提供一种采用所述的镰孢菌 Fusarium proliferatum Nirenberg ECU2002制备手性羟基酸的方法, 包括如下步骤:  In a second aspect of the invention, there is provided a method of preparing a chiral hydroxy acid using the Fusarium proliferatum Nirenberg ECU 2002, comprising the steps of:
(1) 培养所述的镰孢菌 Fusarium proliferatum Nirenberg ECU2002 , 获得培 养物;  (1) cultivating the Fusarium proliferatum Nirenberg ECU2002 to obtain a culture;
(2) 将步骤 (1)的培养物或其提取物与外消旋手性内酯底物 (gP ( ± 内酯底 物;)接触, 从而水解 (-)-内酯, 生成 (+)-羟基酸。  (2) contacting the culture of step (1) or its extract with a racemic chiral lactone substrate (gP (± lactone substrate;) to hydrolyze (-)-lactone to form (+) - Hydroxy acid.
在另一优选例中,  In another preferred example,
在步骤(1)中, 将所说的镰孢菌 Fusarium proliferatum Nirenberg ECU2002 在包含碳、 氮、 磷及无机盐的培养基中进行发酵, 获得培养物;  In the step (1), the Fusarium proliferatum Nirenberg ECU2002 is fermented in a medium containing carbon, nitrogen, phosphorus and an inorganic salt to obtain a culture;
在步骤 (2)中, 将步骤 ( 1)获得的培养物或其提取物作为催化剂, 催化内酯 底物的对映选择性水解, 分离去除未被水解的 (+)-内酯, 获得由 (-)-内酯水解生 成的 (+)-羟基酸;  In the step (2), the culture obtained in the step (1) or the extract thereof is used as a catalyst to catalyze the enantioselective hydrolysis of the lactone substrate, and the unhydrolyzed (+)-lactone is separated and removed, and obtained by (-)-hydroxy acid formed by hydrolysis of lactone;
所说的内酯底物包括 (但不限于;): β-丁内酯, α-羟基 -γ-丁内酯, α-羟基 -β,β- 二甲基 -γ-丁内酯, α-乙酰基 -γ-丁内酯, β-羟基 -γ-丁内酯, 正丁基苯酞等。 Said lactone substrate includes (but is not limited to): β-butyrolactone, α-hydroxy-γ-butyrolactone, α-hydroxy-β, β- Dimethyl-γ-butyrolactone, α-acetyl-γ-butyrolactone, β-hydroxy-γ-butyrolactone, n-butylphthalide, and the like.
在另一优选例中, 在步骤 (2)中, 所述培养物的提取物选自:  In another preferred embodiment, in the step (2), the extract of the culture is selected from the group consisting of:
将所述的培养物进行离心或过滤后获得的菌丝体;  a mycelium obtained by centrifuging or filtering the culture;
将所述的培养物去除菌体后获得的发酵上清液;  a fermentation supernatant obtained after removing the culture body from the culture;
将菌丝体破碎, 抽提得到的无细胞提取液; 或  a cell-free extract obtained by disrupting the mycelium and extracting it; or
固定化的细胞或固定化的细胞提取物。  Immobilized cells or immobilized cell extracts.
在另一优选例中, 所说的培养基的组成和浓度如下: 甘油 10〜50 g/L, 蛋 白胨 1〜20 g/L,酵母膏 1〜20 g/L, 硝酸铵 l〜10 g/L, 无机盐: NaCl 0.1〜2 g/L; MgSO4'7H2O 0.1〜2 g/L; FeSO4'7H2O 0.01〜0.05 g/L; ZnSO4'7H2O 0.01〜0.05 g/L; CuSO4'5H2O 0.001〜0.01 g/L; In another preferred embodiment, the composition and concentration of the medium are as follows: glycerol 10 to 50 g/L, peptone 1 to 20 g/L, yeast extract 1 to 20 g/L, ammonium nitrate 1 to 10 g/ L, inorganic salt: NaCl 0.1~2 g/L; MgSO 4 '7H 2 O 0.1~ 2 g/L; FeSO 4 '7H 2 O 0.01~0.05 g/L; ZnSO 4 '7H 2 O 0.01~0.05 g/ L; CuSO 4 '5H 2 O 0.001~0.01 g/L;
在另一优选例中, 发酵条件为:  In another preferred embodiment, the fermentation conditions are:
pH 5〜9, 温度 25〜35 。C, 基于发酵培养基体积的接种量按照体积比为 1〜10%, 发酵时间 12-48 ho  pH 5~9, temperature 25~35. C, the inoculum based on the volume of the fermentation medium is 1 to 10% by volume, and the fermentation time is 12-48 ho.
在另一优选例中,内酯底物的浓度按照重量体积比为 1〜75%, 基于底物内 酯重量的催化剂使用量为 0.25〜1.5 克细胞 /克内酯或者 0.25〜10单位酶 /克内 酯, 反应温度为 25〜40 °C, pH 6.0〜8.0, 反应时间为 0.1-40 ho  In another preferred embodiment, the concentration of the lactone substrate is from 1 to 75% by weight, and the amount of the catalyst based on the weight of the substrate lactone is from 0.25 to 1.5 grams of cells per gram of lactone or 0.25 to 10 units of enzyme per Ketone, reaction temperature is 25~40 °C, pH 6.0~8.0, reaction time is 0.1-40 ho
在另一优选例中, 所述的内酯底物为 (±)-α-羟基 -γ-丁内酯。  In another preferred embodiment, the lactone substrate is (±)-α-hydroxy-γ-butyrolactone.
在另一优选例中, 所述的内酯底物为 (±)-泛解酸内酯。  In another preferred embodiment, the lactone substrate is (±)-pantolactone.
在另一优选例中, 催化剂为下列形式中的任意一种:  In another preferred embodiment, the catalyst is in any of the following forms:
(1) 将镰孢菌 ECU2002 进行液体或固体培养后通过离心或过滤收集到的 菌丝体;  (1) Mycelium collected by centrifugation or filtration after the Fusarium ECU2002 is cultured in liquid or solid;
(2) 去除菌体后所剩余的发酵上清液;  (2) The fermentation supernatant remaining after removing the cells;
(3) 采用研磨或匀浆等方法将菌丝体破碎, 再用水或缓冲液抽提所得的无 细胞提取液;  (3) crushing the mycelium by grinding or homogenizing, and extracting the obtained cell-free extract with water or buffer;
(4) 固定化细胞或固定化酶。  (4) Immobilized cells or immobilized enzymes.
在另一优选例中, 在步骤 (2) 之后, 还包括步骤: 将 ( + )-羟基酸在酸性条 件下脱水闭环, 从而获得 (-)-内酯。  In another preferred embodiment, after the step (2), the method further comprises the step of: dehydrating the (+)-hydroxy acid under acidic conditions to obtain a (-)-lactone.
更优选的, 所述的酸性条件是 pH 1〜4。  More preferably, the acidic condition is pH 1-4.
在本发明的第三方面, 提供所述的镰孢菌的用途, 其特征在于, 用于产生 左旋内酯水解酶催化剂, 从而用于制备手性羟基酸或者手性内酯。 本发明提到的左旋内酯酶产生菌一镰孢菌(又称镰孢霉菌) F^ar/w proliferatum Nirenberg ECU2002 , 是最近从土壤中新分离到的一株专一性 (-) - 内酯水解酶产生菌, 该菌株已于 2005年 10月 17 日保藏在中国普通微生物菌 种保藏中心 (CGMCC) , 保藏号为 CGMCC 1494。 In a third aspect of the invention, there is provided the use of the Fusarium bacterium, characterized in that it is used to produce a L-lactone hydrolase catalyst for the preparation of a chiral hydroxy acid or a chiral lactone. The L-lactone-producing bacterium of the present invention, Fusarium oxysporum (also known as Fusarium) F^ar/w proliferatum Nirenberg ECU2002, is a uniquely isolated (-)-separated from the soil recently. Ester hydrolase-producing bacteria, which was deposited at the China General Microorganisms Collection (CGMCC) on October 17, 2005, with the accession number CGMCC 1494.
本发明菌株的分离筛选方法简述如下:  The separation and screening methods of the strains of the present invention are briefly described as follows:
采集了不同环境条件下 400份土壤样品, 分别使用 γ-丁内酯, DL-泛解酸 内酯, DL-泛解酸钠, D-泛酸钙, D- (-) -泛解酸内酯, L-(+)-泛解酸内酯, 或 D- 泛解酸钠等为唯一碳源进行富集培养, 筛选 (-)-内酯水解酶产生菌。  400 soil samples under different environmental conditions were collected, using γ-butyrolactone, DL-pantolactone, DL-pantothenate, D-calcium pantothenate, D-(-)-pantolactone , L-(+)-pantolactone, or D-pantothenate is the only carbon source for enrichment culture, and the (-)-lactone hydrolase-producing bacteria are screened.
(1) 将土样置于试管中, 加入 2 mL富集培养基 A (g/L) (底物 1.0, NaNO3 4.0, KH2PO4 4.0, MgSO4 0. 1, KC1 0.5 , ZnSO4-7H2O 0. 1 , CuSO4'5H2O 0.05), 在 30 °C, 200 r/min富集培养 1天, 保留有明显微生物生长迹象的试管, 每管 取 0.2 mL富集培养液,加入装有 1.8 mL已灭菌的富集培养基 B (g/L)(底物 5.0, NaNO3 4.0, KH2PO4 4.0, MgSO4 0. 1, KC1 0.5 , ZnSO4-7H2O 0. 1 , CuSO4-5H2O 0.05), 在 30 °C, 200 r/min培养 1〜2天, 每管取 0. 1 mL富集培养液涂布于加 有溴酚蓝指示剂的平板培养基 C (g/L) (底物 5.0, 甘油 10, 酵母膏 7.5, 蛋白胨 7.5, 琼脂 20)上, 30 °C培养 2〜3天。 有水解活性的菌株在平板培养基 C上产 生水解圈,菌落周围的培养基由蓝色变为黄色,经进一步分离纯化获得单菌落。 (1) Place the soil sample in a test tube and add 2 mL of enrichment medium A (g/L) (substrate 1.0, NaNO 3 4.0, KH 2 PO 4 4.0, MgSO 4 0.1, KC1 0.5 , ZnSO 4 -7H 2 O 0. 1 , CuSO 4 '5H 2 O 0.05), enriched for 1 day at 200 °C/min at 30 °C, retaining tubes with obvious signs of microbial growth, 0.2 mL of enriched medium per tube Add 1.8 mL of sterilized enriched medium B (g/L) (substrate 5.0, NaNO 3 4.0, KH 2 PO 4 4.0, MgSO 4 0.1, KC1 0.5 , ZnSO 4 -7H 2 O 0. 1 , CuSO 4 -5H 2 O 0.05), cultured at 30 ° C, 200 r / min for 1 to 2 days, each tube took 0.1 mL of enriched culture solution coated with bromophenol blue indicator Plate medium C (g/L) (substrate 5.0, glycerol 10, yeast extract 7.5, peptone 7.5, agar 20) was incubated at 30 ° C for 2 to 3 days. The hydrolyzed strain produced a hydrolyzed circle on the plate medium C, and the medium surrounding the colony changed from blue to yellow, and further separated and purified to obtain a single colony.
(2) 将单菌落接种到 100 mL丰富培养基 D (甘油 10, 酵母膏 7.5, 蛋白胨 7.5), 30。C, 160 r/min培养 2〜3天。经过抽滤或者离心得到湿菌体,加入 10 mL 磷酸钾缓冲液 ( 100 mM, pH 7.0)和 1% (w/v)的底物 α-羟基 -γ-丁内酯, 在 30 °C, 160 r/min反应 12 h。 加入乙酸乙酯萃取剩余底物, 将剩余水相中的产物内酯化 后用乙酸乙酯萃取, 取样分析水解产物羟基酸和剩余底物内酯的光学纯度。  (2) Inoculate a single colony into 100 mL of rich medium D (glycerol 10, yeast extract 7.5, peptone 7.5), 30. C, 160 r/min culture for 2 to 3 days. After filtration or centrifugation to obtain wet cells, 10 mL of potassium phosphate buffer (100 mM, pH 7.0) and 1% (w/v) of substrate α-hydroxy-γ-butyrolactone were added at 30 °C. 160 r / min reaction for 12 h. The remaining substrate was extracted with ethyl acetate, the product in the remaining aqueous phase was lactonized, and extracted with ethyl acetate. The optical purity of the hydrolyzed hydroxy acid and the remaining substrate lactone was analyzed by sampling.
(3) 通过反复筛选, 分离得到一株产专一性 (-)-内酯水解酶的镰孢菌株 (Fusarium proliferatum Nirenberg EGU2002)。 所说的镰孢菌 (F^ar/w proliferatum Nirenberg ECU2002)具有如下微生物 学特征:  (3) A strain of Fusarium proliferatum (Nirenberg EGU2002) producing a specific (-)-lactone hydrolase was isolated by repeated screening. The Fusarium (F^ar/w proliferatum Nirenberg ECU2002) has the following microbiological characteristics:
在固体培养基上培养三天, 产生大量粉红色基内菌丝, 其气生菌丝呈白色 绒毛状, 有黄色色素产生, 其菌落直径约为 25 mm; 在液体培养基中为丝状体, 初期有较多小型分生孢子, 大小为 6〜15 μηι Χ 3〜4 μηι, 后期有褐色色素产生。 分生孢子梗分枝, 孢子梗长约 25 μηι, 聚生或散生, 小分生孢子以链状着生于 散生或聚生的孢子梗上,在低倍显微镜下观察,在孢子梗上,分生孢子链呈 " V " 型。 没有观察到大型分生孢子, 也无厚垣孢子, 可在温度 10〜60 °C, pH 4.0〜 9.0和 NaCl浓度 0〜7% (w/v)的环境中生存。 Cultured on solid medium for three days, producing a large number of pink intracellular hyphae, the aerial hyphae are white fluffy, with yellow pigment, the colony diameter is about 25 mm; filaments in liquid medium At the beginning, there are many small conidia, the size is 6~15 μηι Χ 3~4 μηι, and brown pigment is produced in the later stage. Branches of conidiophores, spore stalks ca. 25 μηι, aggregated or scattered, small conidia stalks stalked into sessile or sessile spores, observed under a low-power microscope, in spore stalks On, the conidia chain is "V" type. Large conidia were not observed, and no chlamydospores were found, which could survive in an environment with a temperature of 10 to 60 ° C, a pH of 4.0 to 9.0, and a NaCl concentration of 0 to 7% (w/v).
该菌株经德国 DSMZ公司鉴定为 Fusarium proliferatum Nirenberg类群。与 以前文献 Microbiol. Biotechnol, 1995, 44: 333〜338; Process Biochem, 2002, 38 : 545〜 549)报道的 Fusarium moniliforme SW-902 禾口 Fusarium ox pora AKU3702有明显的不同, 其主要不同之处在于: 本发明的 F^ar/w proliferatum ECU2002 为粉红色真菌, 初期有较多小型分生孢子, 产酶发酵时 间较短为 1〜2天, 而文献报道的 Fusarium moniliforme SW-902禾口 Fusarium oxysporum AKU3702 为白色真菌, 其孢子呈珠状较大, Fusarium moniliforme SW-902产酶发酵时间为 2〜3天, F ari謹 oxysporum AKU3702产酶发酵时 间较长为 5〜7天, 而 Fusarium oxysporum AKU3702更是一种植物致病菌。 此 外, 本发明的 Fusarium proliferatum ECU2002能水解多种内酯底物生成相应的 手性羟基酸, 并且对底物的浓度耐受性很强, 如催化 D- (-) -泛解酸内酯水解时 底物浓度可高达 75% w/v (;文献报道的底物浓度一般为 10〜30%, w/v), 经过重 结晶后, 产物 (-)-内酯的光学纯度超过 99% ee。  This strain was identified as a Fusarium proliferatum Nirenberg group by the German DSMZ company. There are significant differences between the Fusarium moniliforme SW-902 and the Fusarium ox pora AKU3702 reported in the previous literature Microbiol. Biotechnol, 1995, 44: 333~338; Process Biochem, 2002, 38: 545~549). The main difference is that The F^ar/w proliferatum ECU2002 of the present invention is a pink fungus, and has many small conidia in the initial stage, and the enzyme fermentation time is as short as 1 to 2 days, while the Fusarium moniliforme SW-902 and Fusarium oxysporum reported in the literature. AKU3702 is a white fungus with spores larger in beads. The fermentation time of Fusarium moniliforme SW-902 is 2~3 days. The fermentation time of F ari oxysporum AKU3702 is 5~7 days longer, while Fusarium oxysporum AKU3702 is more. It is a phytopathogenic bacterium. In addition, the Fusarium proliferatum ECU 2002 of the present invention can hydrolyze various lactone substrates to form corresponding chiral hydroxy acids, and is highly resistant to the concentration of the substrate, such as catalyzing the hydrolysis of D-(-)-pantolactone. The substrate concentration can be as high as 75% w/v (the substrate concentration reported in the literature is generally 10 to 30%, w/v). After recrystallization, the optical purity of the product (-)-lactone exceeds 99%. .
本发明的镰孢菌 (F^ar/w proliferatum Nirenberg ECU2002)可以用于制备 手性羟基酸, 包括如下步骤:  The Fusarium oxysporum (F^ar/w proliferatum Nirenberg ECU2002) of the present invention can be used to prepare a chiral hydroxy acid, and includes the following steps:
(1) 将所说的镰孢菌 ( ¾sar/w proliferatum Nirenberg ECU2002)在包含碳、 氮、 磷及其它无机盐的培养基中进行发酵, 获得培养物;  (1) fermenting said Fusarium (3⁄4sar/w proliferatum Nirenberg ECU2002) in a medium containing carbon, nitrogen, phosphorus and other inorganic salts to obtain a culture;
所说的培养基的组成和浓度 (g/L)如下:  The composition and concentration (g/L) of the medium are as follows:
甘油 10〜50, 蛋白胨 1〜20, 酵母膏 1〜20, 硝酸铵 1〜10, 无机盐: NaCl 0. 1—2; MgSO4 7H2O 0. 1—2; FeSO4 7H2O 0.01— 0.05 ; ZnSO4 7H2O 0.01— 0.05; CuSO4 5H2O 0.001〜0.01 ; pH 5〜9, 温度 25〜35 。C, 基于培养基体积的接种 量为 1〜10% ν/ν, 培养时间 12〜48小时; Glycerol 10~50, peptone 1~20, yeast extract 1~20, ammonium nitrate 1~10, inorganic salt: NaCl 0. 1-2; MgSO 4 7H 2 O 0. 1-2; FeSO 4 7H 2 O 0.01— 0.05; ZnSO 4 7H 2 O 0.01 - 0.05; CuSO 4 5H 2 O 0.001~0.01; pH 5~9, temperature 25~35. C, the inoculum amount based on the medium volume is 1 to 10% ν / ν, the culture time is 12 to 48 hours;
(2) 将催化剂与需要拆分的底物手性内酯化合物接触, 进行对映选择性催 化水解反应, 然后从反应产物中收集未水解的 (; +)-内酯和由 (-)-内酯水解生成的 (; +)-羟基酸;  (2) contacting the catalyst with a substrate chiral lactone compound to be resolved, performing enantioselective catalytic hydrolysis, and then collecting unhydrolyzed (; +)-lactone from the reaction product and (-)- Hydrolysis of lactone to form (; +)-hydroxy acid;
底物内酯的浓度为 1〜75% (w/v), 基于底物内酯重量的催化剂使用量为 0.25- 1.5克细胞 /克内酯或者 0.25〜10单位酶 /克内酯, 反应温度为 25〜40。C, pH 6.0—8.0, 反应时间为 0. 1— 40 h;  The concentration of the substrate lactone is 1 to 75% (w/v), and the catalyst is used in an amount of 0.25 to 1.5 g of cells per gram of lactone or 0.25 to 10 units of enzyme per gram of lactone based on the weight of the substrate lactone. For 25~40. C, pH 6.0-8.0, reaction time is 0. 1-40 h;
选用 γ-丁内酯作为内酯水解酶活力测定的底物, 采用如下方法测定内酯水 解酶的活力: Using γ-butyrolactone as a substrate for the determination of lactone hydrolase activity, the lactone water was determined by the following method. Enzyme activity:
在 10 mL含有 2 % (^/ν) γ-丁内酯的水相反应体系中, 加入待测的催化剂, 在 30 °C、 磁力搅拌条件下滴加 0.1 M的 NaOH, 维持反应液 pH为 7.0, 测定 消耗 100 μΐ NaOH溶液所需的时间。酶活单位 (U)的定义为:在上述条件下, 1 min 催化 1 μηιοΐ γ-丁内酯水解为对应的羟基酸所需的酶量。  In 10 mL of an aqueous phase reaction system containing 2% (^/ν) γ-butyrolactone, add the catalyst to be tested, and add 0.1 M NaOH at 30 °C under magnetic stirring to maintain the pH of the reaction solution. 7.0, Determine the time required to consume 100 μΐ NaOH solution. The enzyme unit (U) is defined as the amount of enzyme required to catalyze the hydrolysis of 1 μηιοΐ γ-butyrolactone to the corresponding hydroxy acid in 1 min under the above conditions.
所说的催化剂是下列形式中的任意一种:  Said catalyst is any of the following forms:
(1) 将镰孢霉菌 ECU2002进行液体或固体培养后,通过离心或过滤收集到 的菌丝体 (含有大部分 (-) -内酯酶);  (1) Mycelium (containing most (-)-lactonease) collected by centrifugation or filtration after the liquid or solid culture of Fusarium oxysporum ECU2002;
(2)去除菌体后所剩余的发酵上清液 (含有小部分分泌到胞外的游离 (-) -内 酯酶);  (2) The fermentation supernatant remaining after removing the cells (containing a small amount of free (-)-endoesterase secreted into the extracellular space);
(3) 采用研磨或匀浆等方法将菌丝体破碎, 再用水或缓冲液抽提所得的无 细胞提取液;  (3) crushing the mycelium by grinding or homogenizing, and extracting the obtained cell-free extract with water or buffer;
(4) 采用适当的方法, 例如凝胶包埋、 戊二醛交联或载体吸附等, 处理上 述含有活性酶组分的物料所得到的固定化细胞或固定化酶;  (4) using an appropriate method, such as gel embedding, glutaraldehyde cross-linking or carrier adsorption, etc., to treat the immobilized cells or immobilized enzyme obtained by the above-mentioned material containing the active enzyme component;
所说的内酯底物包括但不限于: β-丁内酯, α-羟基 -γ-丁内酯, α-羟基 -β,β- 二甲基 -γ-丁内酯 (;俗称泛解酸内酯;), α-乙酰基 -γ-丁内酯, β-羟基 -γ-丁内酯, 正 丁基苯酞等。  The lactone substrate includes, but is not limited to: β-butyrolactone, α-hydroxy-γ-butyrolactone, α-hydroxy-β, β-dimethyl-γ-butyrolactone (commonly known as a general solution) Acid lactone;), α-acetyl-γ-butyrolactone, β-hydroxy-γ-butyrolactone, n-butylphthalide, and the like.
优选的底物内酯为 (±)-α-羟基 -γ-丁内酯。  A preferred substrate lactone is (±)-α-hydroxy-γ-butyrolactone.
优选的底物内酯为 (±)-泛解酸内酯。  A preferred substrate lactone is (±)-pantolactone.
本发明的菌株产酶稳定, 立体选择性好, 可以直接用发酵获得的菌丝体作 为酶源, 水解拆分外消旋内酯得到高光学纯度的手性羟基酸和剩余内酯。  The strain of the invention has stable enzyme production and good stereoselectivity, and can directly use the mycelium obtained by fermentation as an enzyme source to hydrolyze the racemic lactone to obtain a chiral hydroxy acid with high optical purity and the remaining lactone.
使用本发明的拆分工艺, 能简单方便地获得各种类型的高光学纯度手性羟 基酸, 是一种具有广泛应用前景的生产方法, 可以满足迅速发展的医药工业的 需要, 以下通过具体实施例对本发明的技术内容作进一步的描述。 附图说明  By using the disintegration process of the invention, various types of high optical purity chiral hydroxy acids can be obtained simply and conveniently, and it is a production method with broad application prospects, which can meet the needs of the rapidly developing pharmaceutical industry, and the following The technical content of the present invention is further described by way of example. DRAWINGS
图 1为固定化细胞催化 10% (; wA a-羟基 -γ-丁内酯的多批次水解拆分反应 结果。  Figure 1 shows the results of multi-batch hydrolysis resolution of 10% (; wA a-hydroxy-γ-butyrolactone) catalyzed by immobilized cells.
图 2为固定化细胞催化 20% (; w/v)泛解酸内酯的多批次水解拆分反应结果。 图 3为固定化酶催化 35% (; w/v)泛解酸内酯的多批次水解拆分反应结果。 图 4 为固定化酶催化拆分 75% (; w/v)泛解酸内酯的反应进程。 具体实施方式 Figure 2 shows the results of multi-batch hydrolysis resolution of 20% (; w/v) pantolactone catalyzed by immobilized cells. Figure 3 shows the results of multi-batch hydrolysis resolution of 35% (; w/v) pantolactone catalyzed by immobilized enzyme. Figure 4 shows the progress of the catalytic resolution of 75% (; w/v) pantolactone by immobilized enzyme. detailed description
实施例 1 镰抱霉菌 Fusarium proliferatum ECU2002的发酵培养  Example 1 Fermentation culture of Fusarium proliferatum ECU2002
斜面及平板培养基 (g/L): 甘油 30, 酵母膏 7.5, 蛋白胨 7.5, 琼脂 20。 在 121 °C 灭菌 15分钟, 灭菌后冷却、 制成平板、 接种, 30 °C 培养 2 天。 发 酵培养基 (g/L):甘油 30;蛋白胨 10;酵母膏 10; NH4NO33;无机盐 (g/L) (NaCl 1; MgSO4'7H2O 1; FeSO4'7H2O 0.02; ZnSO47H2O 0.03; CuSO4'5H2O 0.005); pH 7.5。 121 °C灭菌 15分钟, 灭菌后冷却、 接种, 接种量 2%, 在 30 °C, 转速 160 r/min的条件下进行发酵, 培养 2 天菌体干重达到 18 g/L, 产酶可达 90U/L以 上, 比活力为 5 U/g。 实施例 2 细胞碎片的固定化 Bevel and plate medium (g/L): glycerol 30, yeast extract 7.5, peptone 7.5, agar 20. Sterilize at 121 °C for 15 minutes, sterilize, cool, plate, inoculate, and incubate at 30 °C for 2 days. Fermentation medium (g/L): glycerol 30; peptone 10; yeast extract 10; NH 4 NO 3 3; inorganic salt (g/L) (NaCl 1; MgSO 4 '7H 2 O 1; FeSO 4 '7H 2 O 0.02; ZnSO 4 7H 2 O 0.03; CuSO 4 '5H 2 O 0.005); pH 7.5. Sterilize at 121 °C for 15 minutes, sterilize, inoculate, inoculate 2%, inoculate at 30 °C, rotate at 160 r/min, and the dry weight of the cells will reach 18 g/L for 2 days. The enzyme can reach above 90U/L, and the specific activity is 5 U/g. Example 2 Immobilization of cell debris
1) 取 50 g镰孢菌 Fusarium proliferatum ECU2002细胞,加入 5 g石英砂研 磨 1 h进行细胞破壁, 12,000 rpm离心 15 min, 上清液为无细胞抽提液, 沉淀 为细胞碎片。  1) Take 50 g of Fusarium proliferatum ECU2002 cells, grind it with 5 g of quartz sand for 1 h, and centrifuge at 12,000 rpm for 15 min. The supernatant is a cell-free extract and precipitated as cell debris.
2) 取细胞碎片 5g,加入不同的载体,将细胞碎片固定化后测活, 并于 4 °C 贮存 1周后测定其残余活力 (结果见表 1)。  2) Take 5g of cell debris, add different carriers, immobilize the cell debris, and measure the residual activity after storage at 4 °C for 1 week (see Table 1 for the results).
3) 以戊二醛交联固定化的细胞碎片为酶源, (±)-泛解酸内酯为底物, 反应 体积 20mL, 底物浓度为 2 M, 投入固定化细胞碎片 10 g, 反应温度为 30 °C, 滴加 3 M氨水维持反应液 pH恒定在 7.0, 反应 24 h后, 转化率为 34.4%, 产物 (-) -泛解酸内酯的光学纯度为 94.6%。 表 1 不同载体固定细胞碎片的催化活力  3) The cell debris immobilized by glutaraldehyde cross-linking is used as the enzyme source, (±)-pantolactone as the substrate, the reaction volume is 20 mL, the substrate concentration is 2 M, and the immobilized cell debris is put into 10 g. The temperature was 30 °C, 3 M ammonia water was added dropwise to maintain the pH of the reaction solution at 7.0, and after 24 h, the conversion was 34.4%, and the optical purity of the product (-)-pantolactone was 94.6%. Table 1 Catalytic activity of different cell-fixed cell debris
载体 酶活 (U/gcell) 相对活力 (%) 一周后残余活力(%) 无 112±1.9 100±1.7 65.8±0.7  Carrier Enzyme activity (U/gcell) Relative vigor (%) Residual viability after one week (%) None 112±1.9 100±1.7 65.8±0.7
K-卡拉胶 97±1.8 87±1.6 50.1±0.2 明胶 79±1.4 71±1.2 34.0±3.5 琼脂 101±6.2 90±5.5 89±1.4 <≡¾1^據 82±7.9 74±7.0 97±4.9 海藻酸钠 30.6±0.4 27.4±0.4 96±2.4 海藻酸钠 + 壳聚糖 30.0±0.3 26.9±0.3 94±2.8 戊二醛 96.0±1.3 86±1.1 92±3.9 可溶性淀粉 + 戊二醛 103±2.0 92±1.8 37±1.9 硅藻土 + 戊二醛 73±1.8 66±1.6 90±1.2 羟甲基纤维素 + 戊二醛 80±2.5 72±2.3 97±2.4 聚丙烯酰胺 + 戊二醛 59±2.2 53±2.0 88±4.1 戊二醛 + 乙二胺 76±3.4 68±3.0 75±3.7 K-carrageenan 97±1.8 87±1.6 50.1±0.2 gelatin 79±1.4 71±1.2 34.0±3.5 agar 101±6.2 90±5.5 89±1.4 <≡3⁄41^ according to 82±7.9 74±7.0 97±4.9 sodium alginate 30.6±0.4 27.4±0.4 96±2.4 sodium alginate + chitosan 30.0±0.3 26.9±0.3 94±2.8 glutaraldehyde 96.0±1.3 86± 1.1 92±3.9 soluble starch + glutaraldehyde 103±2.0 92±1.8 37±1.9 diatomaceous earth + glutaraldehyde 73±1.8 66±1.6 90±1.2 hydroxymethylcellulose + glutaraldehyde 80±2.5 72±2.3 97±2.4 polyacrylamide + glutaraldehyde 59±2.2 53±2.0 88±4.1 glutaraldehyde + ethylenediamine 76±3.4 68±3.0 75±3.7
实施例 3〜13 Fusarium proliferatum ECU2002固定化细胞对一系列内酯 化合物的水解活力 Example 3~13 Fusarium proliferatum ECU2002 Immobilized cells hydrolyzed against a series of lactone compounds
以下列表 2中一系列内酯为底物, 底物浓度为 ΙΟΟπιΜ, 反应体积 10mL, 投入 0.2 g固定化细胞 (以 15 mM戊二醛在 30°C交联 3 h所得的细胞),在 30。C、 磁力搅拌下反应 0.1〜0.5 h后测定活力。 表 2列出了不同内酯水解时, 固定化 细胞所表现出来的相对活力。 以 γ-丁内酯的活力为 100%, 固定化细胞对结构 比较复杂的内酯(比如说正丁基苯酞;)的水解效果不是很明显, 酶的活力仅为 25%。 固定化细胞对 α-取代内酯表现了很高的活力, 当底物为 α-羟基 -γ-丁内酯 时, 活力最大, 为 γ-丁内酯活力的 54倍之多。 以 (土) -泛解酸内酯和 (-) -泛解酸 内酯为例, 固定化细胞活力分别为 γ-丁内酯活力的 14.7禾 Π 21倍。 表 2. 固定化细胞对一系列内酯化合物的催化活性 实施例号 底物 结构式 相对活性 (%) 实施例 3 γ-丁内酯 100 ± 1 In the following list 2, a series of lactones are substrates, the substrate concentration is ΙΟΟπιΜ, the reaction volume is 10 mL, and 0.2 g of immobilized cells (cells obtained by cross-linking with 15 mM glutaraldehyde at 30 ° C for 3 h) are placed at 30 . C. The activity was measured after 0.1~0.5 h of reaction under magnetic stirring. Table 2 lists the relative viability of immobilized cells when different lactones are hydrolyzed. With the activity of γ-butyrolactone being 100%, the hydrolysis effect of immobilized cells on the more complex lactone (such as n-butylphthalide) is not obvious, and the activity of the enzyme is only 25%. The immobilized cells showed high activity against α-substituted lactone. When the substrate was α-hydroxy-γ-butyrolactone, the activity was the highest, which was 54 times that of γ-butyrolactone. Taking (earth)-pantolactone and (-)-pantolactone as examples, the viable cell viability was 21 times that of γ-butyrolactone 14.7. Table 2. Catalytic Activity of Immobilized Cells on a Series of Lactone Compounds Example No. Substrate Structural Formula Relative Activity (%) Example 3 γ-butyrolactone 100 ± 1
Figure imgf000011_0001
实施例 4 (土) -β-丁内酯 1 184 ± 26
Figure imgf000011_0001
Example 4 (soil) -β-butyrolactone 1 184 ± 26
实施例 5 (±)-α-羟基 -γ-丁内醒 5431 ± 84 实施例 6 (土) -β-羟基 -γ-丁内醒 374 实施例 7 (+)-β-羟基 -γ-丁内醒 129 ± 3 实施例 8 (-) -β-羟基 -γ-丁内醒 517 ± 16 实施例 9 (土) -泛解酸内酯 1468 ± 23Example 5 (±)-α-hydroxy-γ-butyl awake 5541 ± 84 Example 6 (earth) -β-hydroxy-γ-butyl awake 374 Example 7 (+)-β-hydroxy-γ-butyl Wake up 129 ± 3 Example 8 (-) -β-hydroxy-γ-butyl awake 517 ± 16 Example 9 (earth) - pantolactone 1468 ± 23
Figure imgf000012_0001
Figure imgf000012_0001
实施例 10 (-)-泛解酸内酯 2103 ± 4  Example 10 (-)-pantolactone 2103 ± 4
、0  , 0
实施例 1 1 (+)-泛解酸内酯  Example 1 1 (+)-pantolactone
实施例 12 (±)-α-乙酰基 -γ-丁内醒 实施例 13 正丁基苯酞
Figure imgf000012_0002
实施例 14〜: 17 以 Fusarium proliferatum ECU2002粗酶提取物拆分手性内 以 ECU2002粗酶提取物为酶源,(±)-β-丁内酯、(±)-α-羟基 -γ-丁内酯、 (+) -β- 羟基 -γ-丁内酯和 (±)-泛解酸内酯为底物,反应体积 20 mL,底物浓度为 100 mM, 投入粗酶 13 U, 反应温度为 30 °C, 反应时间为 0.2〜 12 h, 滴加 NaOH维持反 应液 pH恒定在 7.0, 通过碱消耗量计算转化率。 通过实验发现 (±)-泛解酸内酯 作为底物时, 选择性水解 (-; )-内酯底物生成( + )-羟基酸, 2 h 转化率即高达 38.2%,而 (十)-羟基酸在酸性条件下 pH= 1, 90 °C加热 0.5 h时转化为 (-)-内酯. 产物 (-)-泛解酸内酯的光学纯度最高达到 98.2% ee。 而 (±)-α-羟基 -γ-丁内酯, 结 果与 (±)-泛解酸内酯相似, 但是它的反应时间大大缩短, 转化率达到 44.2%, 产 生的(十)-羟基酸在酸性条件下 pH= 1, 90 °C加热 0.5 h时转化的产物 (-)-α-羟基 -γ-丁内酯的光学纯度 96.3% ee 时, 仅需 0.2 h,反应初速度也最快, 达 52.6 μΜ/min, 此时酶的对映选择率 (^值;)为 27.6。 表 3内酯酶底的粗提取物对几种手性内酯化合物的催化拆分效果
Example 12 (±)-α-acetyl-γ-butyl awake Example 13 n-butylphenyl hydrazine
Figure imgf000012_0002
Example 14~: 17 The crude enzyme extract of Fusarium proliferatum ECU2002 was used to separate the chirality with ECU2002 crude enzyme extract as the enzyme source, (±)-β-butyrolactone, (±)-α-hydroxy-γ-butyl Lactone, (+)-β-hydroxy-γ-butyrolactone and (±)-pantolactone as substrate, reaction volume 20 mL, substrate concentration 100 mM, input crude enzyme 13 U, reaction temperature The reaction time was 0.2 to 12 h at 30 ° C, and the pH of the reaction solution was kept constant at 7.0 by dropwise addition of NaOH, and the conversion was calculated from the alkali consumption. When the (±)-pantolactone was used as a substrate, the (-; )-lactone substrate was selectively hydrolyzed to form (+)-hydroxy acid, and the conversion rate was as high as 38.2%, and (10) - The hydroxy acid is converted to (-)-lactone under acidic conditions at pH = 1, and heated at 90 °C for 0.5 h. The optical purity of the product (-)-pantolactone is up to 98.2% ee. And (±)-α-hydroxy-γ-butyrolactone, knot The fruit is similar to (±)-pantolactone, but its reaction time is greatly shortened, the conversion rate reaches 44.2%, and the resulting (d)-hydroxy acid is pH=1 under acidic conditions, and 0.5 h when heated at 90 °C. When the optical purity of the converted product (-)-α-hydroxy-γ-butyrolactone is 96.3% ee, only 0.2 h is required, and the initial reaction rate is also the fastest, reaching 52.6 μΜ/min. (^ value;) is 27.6. Catalytic resolution of several chiral lactone compounds by crude extracts from esterase bottoms in Table 3
 Object
实施 初速度 反应 转化 光学纯度  Implementation initial velocity reaction conversion optical purity
例号 ( M/min) 时间 率 (%) 、 +χ  Case number (M/min) Time rate (%), +χ
^ ) ^ 、 内酯 羟基酸 选择率  ^ ) ^, lactone hydroxy acid selectivity
(ees, %) (eeP, %) (E值) 实施 (土) -β-丁内酯 2.6 4 41.0 (ee s , %) (ee P , %) (E value) Implementation (earth) -β-butyrolactone 2.6 4 41.0
例 14
Figure imgf000013_0001
实施 (±)-α-羟基 -γ-丁内 52.6 0.2 44.2 68.0 96.3 26.
Example 14
Figure imgf000013_0001
Implementation of (±)-α-hydroxy-γ-butane 52.6 0.2 44.2 68.0 96.3 26.
例 15  Example 15
ΟΗ  ΟΗ
、八 ,Eight
实施 (土) -β-羟基 -γ-丁内 1.1 12 38.5 46.4 94.8 10.6 例 16 酯
Figure imgf000013_0002
Implementation (soil) -β-hydroxy-γ-butene 1.1 12 38.5 46.4 94.8 10.6 Example 16 ester
Figure imgf000013_0002
实施 (土) -泛解酸内酉 9.8 2 38.2 51.9 98.2 19.2 例 17 Implementation (soil) - pantothenic acid 酉 9.8 2 38.2 51.9 98.2 19.2 Example 17
Figure imgf000013_0003
实施例 18 固定化细胞催化 (±)-α-羟基 -γ-丁内酯的多批次水解反应 (浓度 10% w/v)
Figure imgf000013_0003
Example 18 Immobilized Cell Catalyzed Multi-Batch Hydrolysis of (±)-α-Hydroxy-γ- Butyrolactone (Concentration 10% w/v)
在底物 (±)-α-羟基 -γ-丁内酯浓度为 1 M (10% w/v)的 20 mL反应体系中, 加 入戊二醛交联固定化的细胞 0.1 g, 在 30 °C、 160 rpm的条件下反应 10 h, 加入氨 水调节控制反应的 pH在 6.8〜7.5。 重复操作 10次。 结果如图 1所示, 在 10批次 水解反应后, 固定化酶的活力仅下降了 10%, 酶的半衰期达 36个批次, 在第 10 次水解反应时, 反应的转化率仍然能够维持在 40%左右。 此时产生的 (; + )-羟基酸 在酸性条件下 (pH=3), 80 °C加热 4 h时全部转化为 (-) -α-羟基 -γ-丁内酯。 产物 (-)-α-羟基 -γ-丁内酯的光学纯度保持在 93-96% ee之间。上述结果表明此固定化细 胞在对 α-羟基 -γ-丁内酯进行水解拆分反应时, 具有良好的对映选择性和优异的操 作稳定性。 实施例 19 固定化细胞催化泛解酸内酯的多批次水解反应 (浓度 20% w/v) 在底物 (±)-泛解酸内酯浓度为 1.5 M (20% w/v)的 50 mL反应体系中, 加入 戊二醛交联固定化的细胞 15 g, 在 30 °C、 160 rpm的条件下反应 10 h, 加入氨 水调节控制反应的 pH在 6.5〜7.0。 重复操作 30次, 以游离细胞为对照。 结果 如图 2所示,固定化催化剂可反复回用 30次以上,可进行多次酶促水解反应, 而 且均达到了令人满意的拆分效果, 具有潜在的工业应用价值。 实施例 20 固定化酶催化泛解酸内酯的多批次水解反应 (浓度为 35% w/v)In a 20 mL reaction system with a substrate (±)-α-hydroxy-γ-butyrolactone concentration of 1 M (10% w/v), glutaraldehyde cross-linked cells were added to 0.1 g at 30 °. C, 160 rpm conditions for 10 h, adding ammonia to adjust the pH of the control reaction is 6.8 ~ 7.5. Repeat 10 times. The results are shown in Figure 1. After 10 batches of hydrolysis reaction, the activity of the immobilized enzyme decreased by only 10%, and the half-life of the enzyme reached 36 batches. In the case of the secondary hydrolysis reaction, the conversion of the reaction can still be maintained at about 40%. The (; + )-hydroxy acid produced at this time was completely converted into (-)-α-hydroxy-γ-butyrolactone under acidic conditions (pH=3) and heated at 80 °C for 4 h. The optical purity of the product (-)-α-hydroxy-γ-butyrolactone was maintained between 93-96% ee. The above results indicate that the immobilized cells have good enantioselectivity and excellent operational stability when subjected to hydrolysis-resolving reaction of α-hydroxy-γ-butyrolactone. Example 19 Immobilized cells catalyze the multi-batch hydrolysis of pantolactone (concentration 20% w/v) at a substrate (±)-pantolactone concentration of 1.5 M (20% w/v) In a 50 mL reaction system, 15 g of cells immobilized by glutaraldehyde cross-linking were added, and reacted at 30 ° C, 160 rpm for 10 h, and ammonia was added to adjust the pH of the reaction to 6.5 to 7.0. The operation was repeated 30 times with free cells as a control. As a result, as shown in FIG. 2, the immobilized catalyst can be reused for more than 30 times, and the enzymatic hydrolysis reaction can be carried out multiple times, and both of them have satisfactory resolution effects, and have potential industrial application value. Example 20 Immobilized enzyme catalyzed multi-batch hydrolysis of pantolactone (concentration: 35% w/v)
1) 固定化酶的制备: 在冰浴中, 向细胞粗提液中缓慢加入二分之一体积的 冷丙酮, 缓慢搅拌 0.5 h后加入 20 mM戊二醛交联 4 h, 于 4。C、 14,000 rpm离 心 15 min,并以生理盐水洗涤 2次。 2)在底物 (±)-泛解酸内酯浓度为 2.7 M (35% w/v)的 20 mL反应体系中, 加入 60 U固定化酶, 在 30 °C, 120 rpm的条件下 反应 6 h, 加入氨水 (3 M)调节控制反应的 pH在 6.5〜7.0, 重复操作 10次。 结 果如图 3所示, 在 10 次水解反应后, 固定化酶的活力下降了 33%, 酶的半衰 期大约为 17个批次,产物的光学纯度保持 95% 以上。在第 10次水解反应时, 反应的转化率仍然能够维持在 30%左右, 产物经过 10次反应后累积至大约 30 g o 上述结果表明了此固定化内酯酶具有良好的对映选择性和很好的操作稳定 性。 实施例 21 用固定化酶催化拆分高浓度 (75% w/v)的 (土) -泛解酸内酯 在 20 mL的反应体系中, 加入底物浓度为 5.7 M (;75% W/V)的(;±)-泛解酸内 酯, 并投入 40.0 U的固定化酶, 在 160 rpm, 30 °C反应, 滴加氨水 (3 M)控制反 应 pH 在 7.2。 反应进程如图 4所示, 反应进行 36 h后, 转化率为 36.8%, 此 时产生的( + )-羟基酸在酸性条件下 (pH=2), 80 °C加热 1 h时转化为 (-)-内酯。 产物 (-)-泛解酸内酯的光学纯度仍然 >90%ee。 经过重结晶后产物的光学纯度可 达到〉 99%ee。 实施例 22内酯水解酶基因的克隆 1) Preparation of immobilized enzyme: In an ice bath, a half volume of cold acetone was slowly added to the crude cell extract, slowly stirred for 0.5 h, and then cross-linked with 20 mM glutaraldehyde for 4 h, at 4. C, centrifuge at 154,000 rpm for 15 min, and wash twice with physiological saline. 2) In a 20 mL reaction system with a substrate (±)-pantolactone concentration of 2.7 M (35% w/v), 60 U of immobilized enzyme was added and reacted at 30 ° C and 120 rpm. 6 h, add ammonia water (3 M) to adjust the pH of the control reaction at 6.5~7.0, and repeat the operation 10 times. As a result, as shown in Fig. 3, after 10 hydrolysis reactions, the activity of the immobilized enzyme was decreased by 33%, the half-life of the enzyme was about 17 batches, and the optical purity of the product was maintained at 95% or more. In the 10th hydrolysis reaction, the conversion of the reaction can still be maintained at about 30%, and the product accumulates to about 30 after 10 reactions. The above results indicate that the immobilized lactonase has good enantioselectivity and is very Good operational stability. Example 21 Catalytic resolution of high concentration (75% w/v) of (earth)-pantolactone by immobilized enzyme in a 20 mL reaction system with a substrate concentration of 5.7 M (; 75% W / V ) (; ±)-pantolactone, and put 40.0 U of immobilized enzyme, react at 160 rpm, 30 °C, add ammonia (3 M) to control the reaction pH at 7.2. The progress of the reaction is shown in Fig. 4. After 36 h of reaction, the conversion rate is 36.8%. The (+)-hydroxy acid produced at this time is converted to (at pH=2) under acidic conditions at 80 °C for 1 h. -) - lactone. The optical purity of the product (-)-pantolactone is still >90% ee. The optical purity of the product after recrystallization can be Reach > 99% ee. Example 22 Cloning of the lactone hydrolase gene
1. 取镰孢霉菌丝体 0.5克, 液氮速冻并研磨成粉末, 快速将粉末移入 1.5ml DEPC水处理过的 EP管中, 按总 RNA提取试剂盒说明书提取总 RNA, 取适量 的总 RNA样品, 测定 OD260、 OD280、 OD230的吸光度, 计算总 RNA的浓度 并估计纯度。 同时进行 RNA电泳确定总 RNA的完整性。  1. Take 0.5 g of Fusarium mycelium, freeze it in liquid nitrogen and grind it into powder. Transfer the powder into 1.5 ml DEPC water-treated EP tube, extract total RNA according to the instructions of total RNA extraction kit, and take appropriate amount of total RNA. For the samples, the absorbances of OD260, OD280, and OD230 were measured, and the total RNA concentration was calculated and the purity was estimated. Simultaneous RNA electrophoresis was performed to determine the integrity of total RNA.
2. 从操作 1得到的总 RNA中分离提取 mRNA, 参照生工公司的 mRNA分 离试剂盒说明书进行操作。  2. Isolation and extraction of mRNA from the total RNA obtained in Operation 1, and operating according to the instructions of the Biopolymer Co., Ltd. mRNA isolation kit.
3. 利用生工逆转录试剂盒, 以 2中分离得到的 mRNA为模板, 合成 cDNA 第一链, 参照生工公司 cDNA合成试剂盒说明书进行操作。  3. Using the artificial reverse transcription kit, the mRNA isolated from 2 was used as a template to synthesize the first strand of cDNA, and the instructions were carried out according to the instructions of the Biosynthetics cDNA Synthesis Kit.
4. 根据 mRNA的结构及编码左旋内酯水解酶 cDNA基因的同源序列分析, 设计以下引物:  4. Based on the structure of the mRNA and the homologous sequence analysis of the cDNA encoding the L-lactone hydrolase, the following primers were designed:
弓 I物 1 (SEQ ID NO : 3): GGAACATATGCCTTCTTCCATTTCTGT (画线部分为 Nde I 酶切位点)  弓 I substance 1 (SEQ ID NO: 3): GGAACATATGCCTTCTTCCATTTCTGT (lined part of Nde I restriction site)
引物 2 (SEQ ID NO : 4): GGACCATATGGCTAAGCTTCCTTCTACG  Primer 2 (SEQ ID NO: 4): GGACCATATGGCTAAGCTTCCTTCTACG
弓 I物 3 (SEQ ID NO : 5): AAGGGGATCCCTAATCATAGAGCTTGGGAC (画线部分为 BamHI酶切位点)  弓 I I 3 (SEQ ID NO: 5): AAGGGGATCCCTAATCATAGAGCTTGGGAC (the part of the line is the BamHI restriction site)
分别利用引物 1、 3和引物 2、 3, 以总 cDNA第一链为模板, 扩增左旋内酯 水解酶 cDNA基因, PCR反应参数为 94 °C 30s, 57 °C 30s, 72 °C 80s, 重复 30 个循环后 72 °C继续延伸 10mi n。 用 0. 7%的琼脂糖凝胶电泳鉴定 PCR产物。 PCR 产物约 25μ1, 用 0. 7%的琼脂糖电泳回收目的片段。 利用 DNA胶回收试剂盒进 行回收, 方法见 DNA胶回收试剂盒说明书。  The primers 1, 3 and primers 2 and 3 were used to amplify the L-lactone hydrolase cDNA gene with the first strand of the total cDNA as a template. The PCR parameters were 94 °C for 30 s, 57 °C for 30 s, and 72 °C for 80 s. After repeating 30 cycles, continue to extend 10 min at 72 °C. The PCR product was identified by electrophoresis on a 0.0% agarose gel. The PCR product was approximately 25 μl, and the fragment of interest was recovered by electrophoresis on 0.7% agarose. The DNA gel recovery kit is used for recovery. The method is described in the DNA gel recovery kit.
将回收的目的片段同载体 pMD 18-T (TaKaRa)进行连接, 具体方法按  The recovered target fragment is ligated to the vector pMD 18-T (TaKaRa), and the specific method is as follows.
PMD 18-T载体试剂盒说明书进行, 构建重组质粒 pMD 18-T- 12 (引物 1和引物 3)和 pMD 18-T- 14 (引物 2和引物 3)。 然后按文献的方法将重组质粒电转化到 E. co// JM109宿主菌中。 The PMD 18-T vector kit instructions were used to construct recombinant plasmids pMD 18-T-12 (primer 1 and primer 3) and pMD 18-T-14 (primer 2 and primer 3). The recombinant plasmid was then electroporated into the E. co//JM109 host strain as described in the literature.
将转化后的菌液接种到 3 ml含 50 μ8/ηι1氨苄青酶素(Amp)的 LB培养基中, 37 °C培养过夜。 碱裂解法提取质粒, 用限制性内切酶 Nde I和 BamHI双酶切质 粒用 0. 7%的琼脂糖凝胶电泳鉴定 PCR产物, 筛选阳性克隆菌, 测序验证。 The transformed bacterial solution was inoculated into 3 ml of LB medium containing 50 μ 8 /ηι 1 ampicillin (Amp), and cultured at 37 ° C overnight. The plasmid was extracted by alkaline lysis, and the PCR product was identified by restriction endonuclease Nde I and BamHI. The PCR product was identified by 0.1% agarose gel electrophoresis, and the positive clones were screened and verified by sequencing.
采用引物 1和引物 3进行 PCR, 获得的 PCR产物序列如 SEQ ID NO : 1所示; 利用引物 2和引物 3进行 PCR, 获得的 PCR产物序列如 SEQ ID NO : 2所示。 PCR was carried out using primer 1 and primer 3, and the obtained PCR product sequence is shown in SEQ ID NO: 1. PCR was carried out using primer 2 and primer 3, and the obtained PCR product sequence is shown in SEQ ID NO: 2.
将获得的上述序列在 NCBI上进行核苷酸序列 BLAST分析, 结果发现, 与目前 已知的基因序列均不同。 菌株保藏  The above sequence obtained was subjected to nucleotide sequence BLAST analysis on NCBI, and it was found that it was different from the currently known gene sequences. Strain preservation
本发明的镰孢菌 Fusarium proliferat m Nirenberg ECU2002已于 2005年 10 月 17日保存在中国微生物菌种保藏管理委员会普通微生物中心 (中国, 北京), 编号为 CGMCC 1494。 The Fusarium proliferat m Nirenberg ECU 2002 of the present invention was deposited on October 17, 2005 at the General Microbiology Center of the China Microbial Culture Collection Management Committee (Beijing, China) under the number CGMCC 1494.
申请人或代理人档案号 074483 PCW0 国际申请号 关 于 微 生 物 保 藏 的 说 明 Applicant or Agent File No. 074483 PCW0 International Application No. Note on Microbial Deposits
(细则 13之二)  (Rule 13 bis)
A.对说明书第 _ 14 _页, 第_ 6-8 _行所述的微生物的说明  A. Description of the microorganisms described in the _ 14 _ page, page _ 6-8 _ of the instructions
B.保藏事项  B. Deposits
保藏单位名称 中国微生物菌种保藏管理委员会普通微生物中心 (CGMCC) 保藏单位地址  Name of the depository unit China Microbial Culture Collection Management Committee General Microbiology Center (CGMCC) Depository Address
(包括邮政编码和国名) 中国, 北京 100080  (including zip code and country name) China, Beijing 100080
中国科学院微生物所 保藏日期 2005年 10月 17日 保藏号 CGMCC 1494 Institute of Microbiology, Chinese Academy of Sciences Preservation Date October 17, 2005 Deposit No. CGMCC 1494
C. 补充说明 (必要时) 本栏内容有补充页 □ C. Supplementary explanation (if necessary) Supplementary page in this column □
D. 本说明是为下列指定国作的 (如果说明不是为所有指定国而作的) D. This note is for the following designated countries (if the description is not for all designated countries)
E. 补充说明 (必要时) E. Supplementary explanation (if necessary)
下列说明将随后向国际局提供 (写出说明的类别, 例如 : "保藏的编号" ) The following instructions will then be provided to the International Bureau (write the type of description, eg: "The number of the deposit")
由受理局填写 由国际局填写Filled in by the receiving office, filled in by the International Bureau
□本页已经和国际申请一起收到 □国际局收到本页日期: □ This page has been received with the international application. □ The International Bureau received the date of this page:
受权官员 受权官员  Authorized official
PCT/R0/134表(1992年 7月)  PCT/R0/134 (July 1992)

Claims

权 利 要 求 Rights request
1. 一株产左旋内酉 ^水解酶的镰孢菌 Fusarium proliferatum Nirenberg ECU2002, 保藏号为 CGMCC 1494。 1. A strain of Fusarium proliferatum Nirenberg ECU2002 producing L-endo-hydrolase, deposited under CGMCC 1494.
2. 如权利要求 1所述的镰孢菌, 其特征在于, 所述的菌含有一 DNA, 所 述的 DNA具有 SEQ ID NO: 1中第 86-1206位所示的核苷酸序列。  The Fusarium bacterium according to claim 1, wherein the bacterium contains a DNA having the nucleotide sequence shown in positions 86 to 1206 of SEQ ID NO: 1.
3. 采用权利要求 1 所述的镰孢菌 Fusarium proliferatum Nirenberg ECU2002制备手性羟基酸的方法, 包括如下步骤:  3. A method for preparing a chiral hydroxy acid using the Fusarium proliferatum Nirenberg ECU 2002 of claim 1, comprising the steps of:
(1) 培养所述的镰孢菌 Fusarium proliferatum Nirenberg ECU2002, 获得培 养物;  (1) cultivating the Fusarium proliferatum Nirenberg ECU2002 to obtain a culture;
(2) 将步骤 (1)的培养物或其提取物与外消旋手性内酯底物接触, 从而水解 (-)-内酯, 生成 (+)-羟基酸。  (2) The culture of the step (1) or an extract thereof is contacted with a racemic chiral lactone substrate to hydrolyze (-)-lactone to form a (+)-hydroxy acid.
4. 如权利要求 3所述的方法, 其特征在于,  4. The method of claim 3, wherein
在步骤(1)中, 将所说的镰孢菌 ¾sar/w proliferatum Nirenberg ECU2002 在包含碳、 氮、 磷及无机盐的培养基中进行发酵, 获得培养物;  In the step (1), the Fusarium sp. 3⁄4sar/w proliferatum Nirenberg ECU2002 is fermented in a medium containing carbon, nitrogen, phosphorus and an inorganic salt to obtain a culture;
在步骤 (2)中, 将步骤 (1)获得的培养物或其提取物作为催化剂, 催化内酯底 物的对映选择性水解, 分离除去未被水解的剩余 (+)-内酯, 获得由 (-)-内酯水解 生成的 (+)-羟基酸;  In the step (2), the culture obtained in the step (1) or the extract thereof is used as a catalyst to catalyze enantioselective hydrolysis of the lactone substrate, and the remaining (+)-lactone which is not hydrolyzed is removed to obtain a (+)-hydroxy acid formed by hydrolysis of (-)-lactone;
所说的内酯底物包括: β-丁内酯, α-羟基 -γ-丁内酯, α-羟基 -β,β-二甲基 -γ-丁 内酯, α-乙酰基 -γ-丁内酯, β-羟基 -γ-丁内酯, 正丁基苯酞。 The lactone substrate includes: β-butyrolactone, α-hydroxy-γ-butyrolactone, α -hydroxy-β, β-dimethyl-γ-butyrolactone, α-acetyl-γ- Butyrolactone, β-hydroxy-γ-butyrolactone, n-butylphthalide.
5. 根据权利要求 4所述的方法, 其特征在于, 所说的培养基的组成和浓度 如下:甘油 10〜50 g/L, 蛋白胨 l〜20 g/L,酵母膏 l〜20 g/L, 硝酸铵 l〜10 g/L, 无机盐: NaCl 0.1〜2 g/L; MgSO4'7H2O 0.1〜2 g/L; FeSO4'7H2O 0.01〜0.05 g/L; ZnSO4'7H2O 0.01〜0.05 g/L; CuSO4'5H2O 0.001— 0.01 g/L; 5. The method according to claim 4, wherein the composition and concentration of the medium are as follows: glycerol 10 to 50 g/L, peptone l 20 g/L, yeast paste 1 to 20 g/L , ammonium nitrate 1~10 g/L, inorganic salt: NaCl 0.1~2 g/L; MgSO 4 '7H 2 O 0.1~ 2 g/L; FeSO 4 '7H 2 O 0.01~0.05 g/L; ZnSO 4 ' 7H 2 O 0.01~0.05 g/L; CuSO 4 '5H 2 O 0.001-0.01 g/L;
6. 根据权利要求 4所述的方法, 其特征在于, 发酵条件为:  6. The method according to claim 4, wherein the fermentation conditions are:
pH 5〜9, 温度 25〜35 。C, 基于发酵培养基体积的接种量按照体积比为 1〜10%, 发酵时间 12-48 ho  pH 5~9, temperature 25~35. C, the inoculum based on the volume of the fermentation medium is 1 to 10% by volume, and the fermentation time is 12-48 ho.
7. 根据权利要求 4所述的方法, 其特征在于, 内酯底物的浓度按照重量体 积比为 1〜75%, 基于底物内酯重量的催化剂使用量为 0.25〜1.5克细胞 /克内酯 或者 0.25〜10单位酶 /克内酯,反应温度为 25〜40。C, pH 6.0-8.0, 反应时间为 0.1〜40 h。 7. The method according to claim 4, wherein the concentration of the lactone substrate is from 1 to 75% by weight, and the catalyst is used in an amount of from 0.25 to 1.5 g/g based on the weight of the substrate lactone. Ester or 0.25~10 unit enzyme / gram lactone, the reaction temperature is 25~40. C, pH 6.0-8.0, reaction time is 0.1~40 h.
8. 根据权利要求 4所述的方法, 其特征在于, 催化剂为下列形式中的任意 一种: 8. The method according to claim 4, wherein the catalyst is in any one of the following forms:
(1) 将镰孢菌 ECU2002 进行液体或固体培养后通过离心或过滤收集到的 菌丝体;  (1) Mycelium collected by centrifugation or filtration after the Fusarium ECU2002 is cultured in liquid or solid;
(2) 去除菌体后所剩余的发酵上清液;  (2) The fermentation supernatant remaining after removing the cells;
(3) 采用研磨或匀浆等方法将菌丝体破碎, 再用水或缓冲液抽提所得的无 细胞提取液;  (3) crushing the mycelium by grinding or homogenizing, and extracting the obtained cell-free extract with water or buffer;
(4) 固定化细胞或固定化酶。  (4) Immobilized cells or immobilized enzymes.
9. 如权利要求 3 所述的方法, 其特征在于, 在步骤 (2) 之后, 还包括步 骤: 将 ( + )-羟基酸在酸性条件下脱水闭环, 从而获得 (-)-内酯。  9. The method according to claim 3, further comprising, after the step (2), dehydrating and ring-closing the (+)-hydroxy acid under acidic conditions to obtain a (-)-lactone.
10. 权利要求 1所述的镰孢菌的用途, 其特征在于, 用于产生左旋内酯水 解酶。  The use of Fusarium according to claim 1, which is for producing a L-lactone hydrolase.
PCT/CN2007/070598 2006-10-19 2007-08-30 A levorotatory lactonohydrolase producing strain and its use for producing chiral oxyacid WO2008046328A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007800383401A CN101535467B (en) 2006-10-19 2007-08-30 A levorotatory lactonohydrolase producing strain and its use for producing chiral oxyacid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200610117331.9 2006-10-19
CN2006101173319A CN1935977B (en) 2006-10-19 2006-10-19 Levo lactone hydrolase producing fungus, and its method for preparing chiral hydroxy acid

Publications (2)

Publication Number Publication Date
WO2008046328A1 true WO2008046328A1 (en) 2008-04-24
WO2008046328A8 WO2008046328A8 (en) 2009-07-09

Family

ID=37953721

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2007/070598 WO2008046328A1 (en) 2006-10-19 2007-08-30 A levorotatory lactonohydrolase producing strain and its use for producing chiral oxyacid

Country Status (2)

Country Link
CN (2) CN1935977B (en)
WO (1) WO2008046328A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013160762A3 (en) * 2012-04-26 2014-01-23 Adisseo France S.A.S. A method of production of 2,4-dihydroxybutyric acid
CN113604371A (en) * 2021-08-03 2021-11-05 合肥学院 Yeast strain HF-21 and method for preparing D-pantolactone by two-phase catalysis of yeast strain HF-21
CN114457127A (en) * 2020-09-29 2022-05-10 安徽华恒生物科技股份有限公司 Recombinant engineering bacterium and construction method and application thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1935977B (en) * 2006-10-19 2010-06-09 华东理工大学 Levo lactone hydrolase producing fungus, and its method for preparing chiral hydroxy acid
CN101250492B (en) * 2008-02-29 2010-06-09 华东理工大学 Agrobacterium strain and method for preparing left-lateral lactone compounds thereby
CN101701227B (en) * 2009-11-13 2012-01-11 华东理工大学 Method for preparing optically pure 2-hydroxy-4-phenyl butyric acid with lactonase
CN102120977B (en) * 2010-12-24 2012-08-22 上海应用技术学院 Microbacterium chocolatum and method for preparing (4S,5R)-half ester by using same
CN108102926B (en) * 2017-11-27 2021-04-13 苏州百福安酶技术有限公司 Aspergillus niger strain BFA010-7 for high-yield levorotatory lactone hydrolase and application thereof in preparation of D-pantolactone
CN111850081B (en) * 2019-04-26 2022-03-01 广安摩珈生物科技有限公司 Method for resolving optical isomers using supercritical fluid extraction techniques
CN112028758B (en) * 2020-05-25 2024-09-10 广安摩珈生物科技有限公司 Process for preparing hydroxyaldehydes and process for resolution of optical isomers using electrodialysis technique

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0436730A1 (en) * 1989-08-03 1991-07-17 Fuji Yakuhin Kogyo Kabushiki Kaisha Method of producing d-pantolactone
CN1313402A (en) * 2001-02-21 2001-09-19 浙江鑫富生化股份有限公司 Process for preparing D-lactone valerate by microbe enzyme method
CN1793320A (en) * 2005-12-05 2006-06-28 华东理工大学 Strain of sickle mycete and process for preparing ginseng saponin Rh2 thereof
CN1935977A (en) * 2006-10-19 2007-03-28 华东理工大学 Levo lactone hydrolase producing fungus, and its method for preparing chiral hydroxy acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100351369C (en) * 2005-11-22 2007-11-28 浙江杭州鑫富药业股份有限公司 Microorganism of producing D-pantothenic acid enternal ester hydrolase and process for preparing D-pantothenic acid thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0436730A1 (en) * 1989-08-03 1991-07-17 Fuji Yakuhin Kogyo Kabushiki Kaisha Method of producing d-pantolactone
CN1313402A (en) * 2001-02-21 2001-09-19 浙江鑫富生化股份有限公司 Process for preparing D-lactone valerate by microbe enzyme method
CN1793320A (en) * 2005-12-05 2006-06-28 华东理工大学 Strain of sickle mycete and process for preparing ginseng saponin Rh2 thereof
CN1935977A (en) * 2006-10-19 2007-03-28 华东理工大学 Levo lactone hydrolase producing fungus, and its method for preparing chiral hydroxy acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TANG Y.-X. ET AL.: "Kinetic resolution of DL-pantolactone by immobilized Fusarium moniliforme SW-902", PROCESS BIOCHEMISTRY, vol. 38, no. 4, December 2002 (2002-12-01), pages 545 - 549 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013160762A3 (en) * 2012-04-26 2014-01-23 Adisseo France S.A.S. A method of production of 2,4-dihydroxybutyric acid
CN104254612A (en) * 2012-04-26 2014-12-31 安迪苏法国联合股份有限公司 A method of production of 2,4-dihydroxybutyric acid
KR20150013607A (en) * 2012-04-26 2015-02-05 아디쎄오 프랑스 에스에이에스 A method of production of 2,4-dihydroxybutyric acid
JP2015514433A (en) * 2012-04-26 2015-05-21 アディッソ・フランス・エス.エー.エス.Adisseo France S.A.S. Method for producing 2,4-dihydroxybutyric acid
US9890400B2 (en) 2012-04-26 2018-02-13 Adisseo France S.A.S. Method of production of 2,4-dihydroxybutyric acid
KR102024109B1 (en) 2012-04-26 2019-09-23 아디쎄오 프랑스 에스에이에스 A method of production of 2,4-dihydroxybutyric acid
CN114457127A (en) * 2020-09-29 2022-05-10 安徽华恒生物科技股份有限公司 Recombinant engineering bacterium and construction method and application thereof
CN114457130A (en) * 2020-09-29 2022-05-10 安徽华恒生物科技股份有限公司 Recombinant engineering bacterium and construction method and application thereof
CN113604371A (en) * 2021-08-03 2021-11-05 合肥学院 Yeast strain HF-21 and method for preparing D-pantolactone by two-phase catalysis of yeast strain HF-21
CN113604371B (en) * 2021-08-03 2023-06-16 合肥学院 Yeast strain HF-21 and method for preparing D-pantolactone by double-phase catalysis thereof

Also Published As

Publication number Publication date
CN1935977A (en) 2007-03-28
CN1935977B (en) 2010-06-09
CN101535467B (en) 2013-04-10
CN101535467A (en) 2009-09-16
WO2008046328A8 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
WO2008046328A1 (en) A levorotatory lactonohydrolase producing strain and its use for producing chiral oxyacid
Simpson et al. Microbiological transformations: 49. Asymmetric biocatalysed Baeyer–Villiger oxidation: improvement using a recombinant Escherichia coli whole cell biocatalyst in the presence of an adsorbent resin
WO2006053480A1 (en) A acetoin high yield bacillus pumilus strain
CN113355299B (en) Ketoacid reductase, gene, engineering bacterium and application in synthesis of chiral aromatic 2-hydroxy acid
CN103131659B (en) Organic solvent-resistant lipase, encoding gene thereof, producing strain and application
JP2005516585A (en) Preparation of gallic acid by co-culture
JP2003210164A (en) Hydrolyzing and synthesizing enzyme for capsaicin and method for producing the same
CN106011191A (en) Method for producing 5-aminopentanoic acid by whole-cell biocatalysis
JP2010532992A (en) Microbial kinetic resolution of ethyl 3,4-epoxybutyrate
CN111662939B (en) Method for promoting burkholderia to synthesize toxic flavine by using signal molecules
JPH08508639A (en) Enantioselective hydrolysis of Bouveraria basiana and its derived ketoprofen esters
CN106244505B (en) The method of the application and its yielding lipase of Burkholderia pyrrocinia
KR100463966B1 (en) Preparation Of Dicarboxylic Acid Monoesters From Cyanocarboxylic Acid Esters
Zhang et al. Screening and identification of a cutinase-producing Rhodotorula mucilaginosa and properties of the cutinase
Pegu et al. Isolation and characterization of α-l-rhamnosidase producing bacterium, Agrococcus sp. bkd37, from a warehouse soil and partial optimization of its culture conditions
CN114410604B (en) Epoxide hydrolase and encoding gene and application thereof
JPH0947296A (en) Optical resolution of chlorohydrin by microorganism
CN105755095A (en) Method for synthesizing (R)-2-hydroxy acid by biological enzyme method
CN111718919A (en) Culture medium for producing esterifying enzyme and preparation method of crude esterifying enzyme preparation
JPH04248989A (en) Production of 8-hydroxycarbostyril and/or 8-hydroxycoumarin
CN115786295A (en) L-pantolactone dehydrogenase, coding gene and application
JP3917723B2 (en) Lactone hydrolase and process for producing the same
JP3892427B2 (en) Method for producing hydroxycitric acid
CN115975826A (en) Saccharomyces cerevisiae mSte 003 and application thereof in production of beta-arbutin
CN117866777A (en) Fusarium graminearum for producing xylose, and culture method and application thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780038340.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07785480

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07785480

Country of ref document: EP

Kind code of ref document: A1